(3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
You are invited to
attend the 2017 Annual Meeting of Stockholders of Anavex Life Sciences Corp. which will be held on Tuesday, April 18,
2017,
10:00 a.m., local time, at the offices of Nasdaq MarketSite, 4 Times Square, New York, NY 10036.
Details regarding the
meeting and the business to be conducted are described in the accompanying proxy statement. In addition to considering the matters
described in the proxy statement, we will report on matters of interest to our stockholders.
Whether or not you
plan to attend the meeting, we encourage you to vote as soon as possible to ensure that your shares are represented at the meeting.
The attached proxy statement explains more about proxy voting, so please read it carefully.
It is important that
your shares be represented at the 2017 Annual Meeting of Stockholders of Anavex Life Sciences Corp. regardless of the number of
shares you hold.
Whether or not you expect to attend the meeting in person, please complete, date, sign and return the accompanying
proxy card in the enclosed envelope to ensure the presence of a quorum at the meeting.
Even if you have voted by proxy, and
you attend the meeting, you may, if you prefer, revoke your proxy and vote your shares in person.
Please note, however, that
if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you will not be permitted
to vote in person at the meeting unless you first obtain a legal proxy issued in your name from the record holder.
This proxy statement
is dated March 10, 2017 and is going to be first mailed to stockholders of Anavex Life Sciences Corp. on or about March 10, 2017.
This proxy statement contains information on matters to be voted upon at the 2017 Annual Meeting of Stockholders of Anavex Life
Sciences Corp. or any adjournments of that meeting.
The proxy statement and 2016 annual report to stockholders are
available at www.proxyvote.com.
FORM 10-K ANNUAL REPORT
TO STOCKHOLDERS
On December 14, 2016,
the Company filed with the SEC its Annual Report on Form 10-K for the fiscal year ended September 30, 2016. We have enclosed the
Annual Report with this proxy statement. The Annual Report includes our audited financial statements for the fiscal year ended
September 30, 2016, along with other financial information and management discussion which we urge you to read carefully. As filed
with the SEC, our Annual Report contains the following exhibit, which is not being furnished herewith, but which we will provide
free of charge upon request: (1) Business Code of Conduct & Ethics.
You can also obtain, free of charge, a copy
of our Annual Report and all exhibits thereto by:
|
•
|
writing to:
Anavex Life Sciences Corp.
51 W 52
nd
Street, 7
th
Floor, New York,
NY 10019
Attention: Christopher U. Missling, PhD., Chief Executive Officer
|
|
|
|
|
•
|
telephoning us at: 844.689.3939
|
You can obtain a copy of our Annual Report
and other periodic filings that we make with the SEC at
www.anavex.com
or from the SEC’s EDGAR database at
http://www.sec.gov
.
2017
MEETING PROXY MATERIALS RESULTS
Copies of this proxy statement and proxy
materials ancillary hereto may be found on our website at
www.anavex.com
and at
www.proxyvote.com
. We intend
to publish final results from the 2017 Meeting in a Current Report on Form 8-K, which will be filed with the SEC within four
(4) business days from the 2017 Meeting, or as amended thereafter. You may obtain a copy of this and other reports free of charge
at or the SEC at (800) 732-0330 or
http://www.sec.gov
.
DELIVERY
OF DOCUMENTS TO STOCKHOLDERS SHARING AN ADDRESS
Only one Proxy Statement
is being delivered to two (2) or more stockholders who share an address, unless the Company has received contrary instruction from
one (1) or more of such stockholders. The Company will promptly deliver, upon written or oral request, a separate copy of the proxy
statement to a stockholder at a shared address to which a single copy of the document was delivered. If you would like to request
additional copies of the proxy statement, or if in the future you would like to receive multiple copies of information or proxy
statements, or annual reports, or, if you are currently receiving multiple copies of these documents and would, in the future,
like to receive only a single copy, please so instruct the Company by writing to us at 51 W 52nd Street, 7th Floor, New York, NY
10019 Attention: Christopher Missling, PhD. or telephoning us at 844.689.3939.
STOCKHOLDER RIGHTS AGREEMENT
RIGHTS AGREEMENT, dated
as of ________ ___, 2017 (the “
Agreement
”), between Anavex Life Sciences Corp., a Nevada corporation (the “
Company
”),
and ____________________________ (the “
Rights Agent
”).
WITNESSETH
WHEREAS, on ________ ___,
2017 (the “
Rights Dividend Declaration Date
”), the Board of Directors of the Company (the “
Board
”)
authorized and declared a dividend distribution of one Right for each share of common stock, par value $0.001 per share, of the
Company (the “
Common Stock
”) outstanding at the close of business on ________ ___, 2017 (the “
Record
Date
”), and has authorized the issuance of one Right (as such number may hereinafter be adjusted pursuant to the provisions
of Section 11(o) hereof) for each share of Common Stock of the Company issued between the Record Date (whether originally issued
or delivered from the Company’s treasury) and the Distribution Date, each Right initially representing the right to purchase
one share of Common Stock, upon the terms and subject to the conditions hereinafter set forth (the “
Rights
”);
NOW, THEREFORE, in consideration
of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:
Section 1.
Certain
Definitions.
For purposes of this Agreement, the following terms have the meanings indicated:
(a) “
Acquiring
Person
” shall mean any Person who or which, together with all Affiliates and Associates of such Person, shall be the
Beneficial Owner of ten percent or more of the shares of Common Stock then outstanding, but shall not include (i) the Company;
(ii) any Subsidiary of the Company; (iii) any employee benefit plan of the Company, or of any Subsidiary of the Company,
or any Person or entity organized, appointed or established by the Company for or pursuant to the terms of any such plan; (iv)
any Person who becomes the Beneficial Owner of ten percent or more of the shares of Common Stock then outstanding as a result
of a reduction in the number of shares of Common Stock outstanding due to the repurchase of shares of Common Stock by the Company
unless and until such Person, after becoming aware that such Person has become the Beneficial Owner of ten percent or more of
the then-outstanding shares of Common Stock, acquires beneficial ownership of additional shares of Common Stock representing one
percent or more of the shares of Common Stock then outstanding; (v) any Person which beneficially owns ten percent or more of
the shares of Common Stock outstanding on the date hereof, unless and until such time as such Person together with its Affiliates
and Associates, directly or indirectly, becomes the Beneficial Owner of fifteen percent or more of the shares of Common Stock
then outstanding, in which event such Person shall immediately become an Acquiring Person; and (vi) any Person who has reported
or is required to report such ownership (but less than fifteen percent) on Schedule 13G under the Exchange Act (or any comparable
or successor report) or on Schedule 13D under the Exchange Act (or any comparable or successor report) which Schedule 13D does
not state any intention to or reserve the right to control or influence the management or policies of the Company or engage in
any of the actions specified in Item 4 of such schedule (other than the disposition of the Common Stock) and, within ten Business
Days of being requested by the Company to advise it regarding the same, certifies to the Company that such Person acquired shares
of Common Stock in excess of 9.99% inadvertently or without knowledge of the terms of the Rights and who or which, together with
all Affiliates and Associates, thereafter within ten Business Days following such certification reduces such Person’s, together
with its Affiliates’ and Associates’ Beneficial Ownership to less than ten percent of the shares of Common Stock then
outstanding; provided, however, that (x) if the Person requested to so certify fails to do so within ten Business Days or breaches
or violates such certification, then such Person shall become an Acquiring Person immediately after such ten Business Day period
or such breach or violation or (y) if the Person together with its Affiliates and Associates fails to reduce such Person’s,
together with its Affiliate’s and Associate’s, Beneficial Ownership to less than ten percent within ten Business Days
following such certification, then such Person shall become an Acquiring Person immediately after such ten Business Day period.
(b) “
Act
”
shall mean the Securities Act of 1933, as amended.
(c) “
Adjustment
Shares
” shall have the meaning set forth in Section 11(a)(ii) hereof.
(d) “
Affiliate
”
and “
Associate
” shall have the respective meanings ascribed to such terms in Rule 12b-2 of the General Rules
and Regulations under the Exchange Act.
(e) “
Agreement
”
shall mean this Rights Agreement between the Company and the Rights Agent.
(f) A
Person shall be deemed the “
Beneficial Owner
” of, and shall be deemed to “
beneficially own,
”
any securities:
(i) which
such Person or any of such Person’s Affiliates or Associates, directly or indirectly, owns or has the right to acquire (whether
such right is exercisable immediately or only after the passage of time or upon the satisfaction of one or more conditions (whether
or not within the control of such Person) pursuant to any agreement, arrangement, or understanding (whether or not in writing)
or upon the exercise of conversion rights, exchange rights, rights, warrants or options, or otherwise; provided, however, that
a Person shall not be deemed the “Beneficial Owner” of, or to “beneficially own,” (A) securities tendered
pursuant to a tender or exchange offer made by such Person or any of such Person’s Affiliates or Associates until such tendered
securities are accepted for purchase or exchange, or (B) securities issuable upon exercise of Rights at any time prior to the
occurrence of a Triggering Event, or (C) securities issuable upon exercise of Rights from and after the occurrence of a Triggering
Event which Rights were acquired by such Person or any of such Person’s Affiliates or Associates prior to the Distribution
Date or pursuant to Section 3(a) or Section 22 hereof (the “
Original Rights
”) or pursuant to Section 11(i)
hereof in connection with an adjustment made with respect to any Original Rights;
(ii) which
such Person or any of such Person’s Affiliates or Associates, directly or indirectly, has the right to vote or dispose of
or has “beneficial ownership” of (as determined pursuant to Rule 13d-3 of the General Rules and Regulations under
the Exchange Act), including pursuant to any agreement, arrangement, or understanding, whether or not in writing; provided, however,
that a Person shall not be deemed the “Beneficial Owner” of, or to “beneficially own,” any security under
this subparagraph (ii) as a result of an agreement, arrangement, or understanding to vote such security if such agreement, arrangement,
or understanding: (A) arises solely from a revocable proxy given in response to a public proxy or consent solicitation made pursuant
to, and in accordance with, the applicable provisions of the General Rules and Regulations under the Exchange Act, and (B) is
not also then reportable by such Person on Schedule 13D under the Exchange Act (or any comparable or successor report);
(iii) which
are beneficially owned, directly or indirectly, by any other Person (or any Affiliate or Associate thereof) with which such Person
(or any of such Person’s Affiliates or Associates) has any agreement, arrangement, or understanding (whether or not in writing),
(A) for the purpose of acquiring, holding, voting (except pursuant to a revocable proxy as described in the proviso to subparagraph
(ii) of this definition of “Beneficial Owner” and “beneficially own”), or disposing of any voting securities
of the Company, or (B) to cooperate in obtaining, changing, or influencing the control of the Company; provided, however, that
nothing in this definition of “Beneficial Owner” and “beneficially own” shall cause a person engaged in
business as an underwriter of securities to be the “Beneficial Owner” of, or to “beneficially own,” any
securities acquired through such person’s participation in good faith in a firm commitment underwriting until the expiration
of forty days after the date of such acquisition; and provided further, however, that any stockholder of the Company, with Affiliate(s),
Associate(s), or other Person(s) who may be deemed representatives of it serving as director(s) of the Company, shall not be deemed
to beneficially own securities held by other Persons as a result of (i) Persons affiliated or otherwise associated with such stockholder
serving as directors or taking any action in connection therewith; (ii) discussing the status of its shares with the Company or
other stockholders of the Company similarly situated; or (iii) voting or acting in a manner similar to other stockholders similarly
situated, absent a specific finding by the Board of Directors of an express agreement, arrangement, or understanding among such
stockholders to act in concert with one another as stockholders so as to cause, in the good faith judgment of the Board of Directors,
each such stockholder to be the Beneficial Owner of the shares held by the other stockholder(s); or
(iv) which
are the subject of, or the reference securities for, or that underlie, any Derivative Interest of such Person or any of such Person’s
Affiliates and Associates, with the number of shares of Common Stock deemed “beneficially owned” being the notional
or other number of shares of Common Stock specified in the documentation evidencing the Derivative Interest as being subject to
being acquired upon the exercise or settlement of the Derivative Interest or as the basis upon which the value or settlement amount
of such Derivative Interest is to be calculated in whole or in part or, if no such number of shares of Common Stock is specified
in such documentation, as determined by the Board in its sole discretion to be the number of shares of Common Stock to which the
Derivative Interest relates.
(g) “
Business
Day
” shall mean any day other than a Saturday, Sunday, or a day on which banking institutions in the State of New York
are authorized or obligated by law or executive order to close.
(h) “
Close
of business
” on any given date shall mean 5:00 P.M., New York City time, on such date; provided, however, that if such
date is not a Business Day it shall mean 5:00 P.M., New York City time, on the next succeeding Business Day.
(i) “
Common
Stock
” shall mean the common stock, par value $0.001 per share, of the Company, except that “Common Stock”
when used with reference to any Person other than the Company shall mean the capital stock of such Person with the greatest voting
power, or the equity securities or other equity interest having power to control or direct the management, of such Person.
(j) “
Common
Stock Equivalents
” shall have the meaning set forth in Section 11(a)(iii) hereof.
(k) “
Company
”
shall have the meaning set forth in the parties clause at the beginning of this Agreement.
(l) “
Current
Market Price
” shall have the meaning set forth in Section 11(d)(hereof.
(m) “
Current
Value
” shall have the meaning set forth in Section 11(a)(iii) hereof.
(n) “
Derivative
Interest
” shall mean any derivative securities (as defined under Rule 16a-1 under the Exchange Act) that increase in
value as the value of the underlying equity increases, including, but not limited to, a long convertible security, a long call
option, and a short put option position, in each case, regardless of whether (i) such interest conveys any voting rights in such
security; (ii) such interest is required to be, or is capable of being, settled through delivery of such security; or (iii) transactions
hedge the economic effect of such interest.
(o) “
Distribution
Date
” shall have the meaning set forth in Section 3(a) hereof.
(p) “
Equivalent
common stock
” shall have the meaning set forth in Section 11(b) hereof.
(q) “
Exchange
Act
” shall mean the Securities Exchange Act of 1934 as amended.
(r) “
Exchange
Ratio
” shall have the meaning set forth in Section 24(a) hereof.
(s) “
Expiration
Date
” shall have the meaning set forth in Section 7(a) hereof.
(t) “
Final
Expiration Date
” shall have the meaning set forth in Section 7(a) hereof.
(u) “
Nasdaq
”
shall have the meaning set forth in Section 11(d)(i) hereof.
(v) “
Original
Rights
” shall have the meaning set forth in Section 1(f)(i) hereof.
(w) “
Person
”
shall mean any individual, firm, corporation, partnership, joint venture, limited liability company, trust, association, syndicate
or other entity, and shall include any successor (by merger or otherwise) of any of the foregoing.
(x) “
Principal
Party
” shall have the meaning set forth in Section 13(b) hereof.
(y) “
Purchase
Price
” shall have the meaning set forth in Section 4(a) hereof.
(z) “
Record
Date
” shall have the meaning set forth in the WHEREAS clause at the beginning of this Agreement.
(aa) “
Redemption
Price
” shall have the meaning set forth in Section 23(a) hereof.
(bb) “
Rights
”
shall have the meaning set forth in the WHEREAS clause at the beginning of this Agreement.
(cc) “
Rights
Agent
” shall have the meaning set forth in the parties clause at the beginning of this Agreement.
(dd) “
Rights
Certificate
” shall have the meaning set forth in Section 3(a) hereof.
(ee) “
Rights
Dividend Declaration Date
” shall have the meaning set forth in the WHEREAS clause at the beginning of this Agreement.
(ff) “
Section
11(a)(ii) Event
” shall mean any event described in Section 11(a)(ii) hereof.
(gg) “
Section
11(a)(ii) Trigger Date
” shall have the meaning set forth in Section 11(a)(iii) hereof.
(hh) “
Section
13 Event
” shall mean any event described in clauses (x), (y), or (z) of Section 13(a) hereof.
(ii) “
Spread
” shall have the meaning set forth in Section 11(a)(iii) hereof.
(jj) “
Stock
Acquisition Date
” shall mean the first date of public announcement (which, for purposes of this definition, shall include,
without limitation, a report filed pursuant to Section 13(d) under the Exchange Act) by the Company or an Acquiring Person that
an Acquiring Person has become such.
(kk) “
Subsidiary
”
shall mean, with reference to any Person, any corporation or other entity of which an amount of securities or other ownership
interests having ordinary voting power sufficient to elect at least a majority of the directors or other Persons having similar
functions of such corporation or other entity are at the time beneficially owned, directly or indirectly, by such Person, or otherwise
controlled by such Person.
(ll) “
Substitution
Period
” shall have the meaning set forth in Section 11(a)(iii) hereof.
(mm) “
Trading
Day
” shall have the meaning set forth in Section 11(d) hereof.
(nn) “
Triggering
Event
” shall mean any Section 11(a)(ii) Event or any Section 13 Event.
Section 2.
Appointment
of Rights Agent.
The Company hereby appoints the Rights Agent to act as agent for the Company and the holders of the Rights
(who, in accordance with Section 3 hereof, shall prior to the Distribution Date also be the holders of the Common Stock) in accordance
with the terms and conditions hereof, and the Rights Agent hereby accepts such appointment. The Company may from time to time
appoint such co-rights agents (each of whom will be deemed a “Rights Agent” under this Agreement) as it may deem necessary
or desirable, upon five business days’ prior written notice to the Rights Agent; provided, however, that no such advance
notice shall be required in the event of any “force majeure” development as addressed in Section 35 hereof. The Rights
Agent shall have no duty to supervise, and shall in no event be liable for, the acts or omissions of any such co-rights agent.
Section 3.
Issue
of Rights Certificates.
(a) Until
the earlier of (i) the close of business on the tenth Business Day after the Stock Acquisition Date (or, if the tenth Business
Day after the Stock Acquisition Date occurs before the Record Date, the close of business on the Record Date), or (ii) the close
of business on the tenth Business Day (or such later date as the Board shall determine) after the date that a tender or exchange
offer by any Person (other than the Company, any Subsidiary of the Company, any employee benefit plan or compensation plan of
the Company or of any Subsidiary of the Company, or any Person organized, appointed, or established by the Company for or pursuant
to the terms of any such employee benefit or compensation plan) is first published or sent or given within the meaning of Rule
14d-2(a) of the General Rules and Regulations under the Exchange Act, if upon consummation thereof, such Person would become an
Acquiring Person (the earlier of (i) and (ii) being herein referred to as the “
Distribution Date
”), (x) the
Rights will be evidenced (subject to the provisions of paragraph (b) of this Section 3) by the certificates for the Common Stock
registered in the names of the holders of the Common Stock (which certificates for Common Stock shall be deemed also to be certificates
for Rights) and not by separate certificates (or, for shares participating in the direct registration system, by notations in
the respective book entry accounts for the Common Stock), and (y) the Rights will be transferable only in connection with the
transfer of the underlying shares of Common Stock (including a transfer to the Company). As soon as practicable after the Distribution
Date, the Company will prepare and execute, the Rights Agent will countersign, and the Company will send or cause to be sent (and
the Rights Agent will, if requested, send) by first-class, insured, postage-prepaid mail, to each record holder of the Common
Stock as of the close of business on the Distribution Date, at the address of such holder shown on the records of the Company,
one or more right certificates, in substantially the form of
Exhibit A
hereto (the “
Rights Certificates
”),
evidencing one Right for each share of Common Stock so held, subject to adjustment, as provided herein. In the event that an adjustment
in the number of Rights per share of Common Stock has been made pursuant to Section 11(o) hereof, at the time of distribution
of the Rights Certificates, the Company shall make the necessary and appropriate rounding adjustments (in accordance with Section
14(a) hereof) so that Rights Certificates representing only whole numbers of Rights are distributed and cash is paid in lieu of
any fractional Rights. As of and after the Distribution Date, the Rights will be evidenced solely by such Rights Certificates.
(b) The
Company will make available, as promptly as practicable following the Record Date, a copy of a Summary of Rights, in substantially
the form attached hereto as
Exhibit B
(the “
Summary of Rights
”) to any holder of Rights who may so request
from time to time prior to the Expiration Date (as such term is defined in Section 7 hereof). With respect to certificates evidencing
the Common Stock outstanding as of the Record Date, or issued subsequently to the Record Date, until the Distribution Date, the
Rights will be evidenced by such certificates for the Common Stock (or, in the case of book entry shares reflected on the direct
registration system, the notations in the book-entry account system of the transfer agent for the Common Stock) and the registered
holders of the Common Stock shall also be the registered holders of the associated Rights. Until the earlier of the Distribution
Date or the Expiration Date, the transfer of any shares of Common Stock in respect of which Rights have been issued shall also
constitute the transfer of the Rights associated with such shares of Common Stock.
(c) Rights
shall be issued in respect of all shares of Common Stock that are issued (whether originally issued or delivered from the Company’s
treasury) after the Record Date but prior to the earlier of the Distribution Date or the Expiration Date or, in certain circumstances
provided in Section 22 hereof, after the Distribution Date. Certificates representing such shares of Common Stock shall also be
deemed to be certificates for Rights, and shall bear a legend in substantially the following form:
This certificate also
evidences and entitles the holder hereof to certain Rights as set forth in the Rights Agreement between Anavex Life Sciences Corp.
(the “Company”) and the Rights Agent thereunder (the “Rights Agreement”), the terms of which are hereby
incorporated herein by reference and a copy of which is on file at the principal offices of the Company. Under certain circumstances,
as set forth in the Rights Agreement, such Rights will be evidenced by separate certificates and will no longer be evidenced by
this certificate. The Company will mail to the holder of this certificate a copy of the Rights Agreement, as in effect on the
date of mailing, without charge promptly after receipt of a written request therefor. Under certain circumstances set forth in
the Rights Agreement, Rights issued to, or held by, any Person who is, was, or becomes an Acquiring Person or any Affiliate or
Associate thereof (as such terms are defined in the Rights Agreement), whether currently held by or on behalf of such Person or
by any subsequent holder, may become null and void.
With respect to such certificates
containing the foregoing legend, until the earlier of (i) the Distribution Date or (ii) the Expiration Date, the Rights associated
with the Common Stock represented by such certificates shall be evidenced by such certificates alone and registered holders of
Common Stock shall also be the registered holders of the associated Rights, and the transfer of any of such certificates shall
also constitute the transfer of the Rights associated with the Common Stock represented by such certificates. In the case of any
shares participating in the direct registration system, the Company shall cause the transfer agent for the Common Stock to include
on each direct registration account statement with respect thereto issued prior to the Distribution Date a notation to the effect
that the Company will mail to the stockholder a copy of the Rights Agreement, as in effect on the date of mailing, without charge,
promptly after receipt of a written request therefor and that the recipient of the statement, as a holder of shares of Common
Stock, may have certain rights thereunder. In the event that shares of the Common Stock are not represented by certificates, references
in this Agreement to certificates shall be deemed to refer to the notations in the book entry accounts reflecting ownership of
such shares.
Section 4.
Form
of Rights Certificates.
(a) The
Rights Certificates (and the forms of election to purchase and of assignment to be printed on the reverse thereof) shall each
be substantially in the form set forth in
Exhibit A
hereto and may have such changes or marks of identification
or designation and such legends, summaries, or endorsements printed thereon as the Company may deem appropriate and as are not
inconsistent with the provisions of this Agreement, or as may be required to comply with any applicable law or with any rule or
regulation made pursuant thereto or with any applicable rule or regulation of any stock exchange or the Financial Industry Regulatory
Authority, or to conform to usage. Subject to the provisions of Section 11 and Section 22 hereof, the Rights Certificates, whenever
distributed, shall be dated as of the Record Date and on their face shall entitle the holders thereof to purchase such number
of shares of Common Stock as shall be set forth therein at the price set forth therein (such exercise price per share, the “
Purchase
Price
”), but the amount and type of securities purchasable upon the exercise of each Right and the Purchase Price thereof
shall be subject to adjustment as provided herein.
(b) Any
Rights Certificate issued pursuant to Section 3(a) or Section 22 hereof that represents Rights beneficially owned by: (i) an Acquiring
Person or any Associate or Affiliate of an Acquiring Person, (ii) a transferee of an Acquiring Person (or of an Associate or Affiliate
of an Acquiring Person) who becomes a transferee after the Acquiring Person becomes such, or (iii) a transferee of an Acquiring
Person (or of any Associate or Affiliate of an Acquiring Person) who becomes a transferee prior to or concurrently with the Acquiring
Person becoming such and receives such Rights pursuant to either (A) a transfer (whether or not for consideration) from the Acquiring
Person to holders of equity interests in such Acquiring Person or to any Person with whom such Acquiring Person has any continuing
agreement, plan, arrangement, or understanding (whether or not in writing) regarding the transferred Rights, or (B) a transfer
that the Board has determined is part of a plan, arrangement, or understanding (whether or not in writing), which has as a primary
purpose or effect the avoidance of Section 7(e) hereof, and any Rights Certificate issued pursuant to Section 6 or Section 11
hereof upon transfer, exchange, replacement, or adjustment of any other Rights Certificate referred to in this sentence, shall
contain (to the extent feasible) the following legend:
The Rights represented
by this Rights Certificate are or were beneficially owned by a Person who was or became an Acquiring Person or an Affiliate or
Associate of an Acquiring Person (as such terms are defined in the Rights Agreement). Accordingly, this Rights Certificate and
the Rights represented hereby may become null and void in the circumstances specified in Section 7(e) of such Agreement.
Section 5.
Countersignature
and Registration.
(a) The
Rights Certificates shall be executed on behalf of the Company by its Chairman of the Board, its Chief Executive Officer, its
President, or any Vice President, either manually or by facsimile signature, and shall have affixed thereto the Company’s
seal or a facsimile thereof which shall be attested by the Secretary or an Assistant Secretary of the Company, either manually
or by facsimile signature. The Rights Certificates shall be countersigned by the Rights Agent, either manually or by facsimile
signature and shall not be valid for any purpose unless so countersigned. In case any officer of the Company who shall have signed
any of the Rights Certificates shall cease to be such officer of the Company before countersignature by the Rights Agent and issuance
and delivery by the Company, such Rights Certificates, nevertheless, may be countersigned by the Rights Agent and issued and delivered
by the Company with the same force and effect as though the person who signed such Rights Certificates had not ceased to be such
officer of the Company; and any Rights Certificates may be signed on behalf of the Company by any person who, at the actual date
of the execution of such Rights Certificate, shall be a proper officer of the Company to sign such Rights Certificate, although
at the date of the execution of this Rights Agreement any such person was not such an officer.
(b) Following
the Distribution Date, the Rights Agent will keep or cause to be kept, at its principal office or offices designated as the appropriate
place for surrender of Rights Certificates upon exercise or transfer, books for registration and transfer of the Rights Certificates
issued hereunder. Such books shall show the names and addresses of the respective holders of the Rights Certificates, the number
of Rights evidenced on its face by each of the Rights Certificates, and the date of each of the Rights Certificates.
Section 6.
Transfer,
Split Up, Combination, and Exchange of Rights Certificates; Mutilated, Destroyed, Lost, or Stolen Rights Certificates.
(a) Subject
to the provisions of Section 4(b), Section 7(e), and Section 14 hereof, at any time after the close of business on the Distribution
Date, and at or prior to the close of business on the Expiration Date, any Rights Certificate or Certificates (other than Rights
Certificates representing Rights that may have been exchanged pursuant to Section 24 hereof) may be transferred, split up, combined,
or exchanged for another Rights Certificate or Certificates, entitling the registered holder to purchase a like number of shares
of Common Stock (or, following a Triggering Event, other securities, cash, or other assets, as the case may be) as the Rights
Certificate or Certificates surrendered then entitled such holder (or former holder in the case of a transfer) to purchase. Any
registered holder desiring to transfer, split up, combine, or exchange any Rights Certificate or Certificates shall make such
request in writing delivered to the Rights Agent, and shall surrender the Rights Certificate or Certificates to be transferred,
split up, combined, or exchanged at the principal office or offices of the Rights Agent designated for such purpose. Neither the
Rights Agent nor the Company shall be obligated to take any action whatsoever with respect to the transfer of any such surrendered
Rights Certificate until the registered holder shall have completed and signed the certificate contained in the form of assignment
on the reverse side of such Rights Certificate and shall have provided such additional evidence of the identity of the Beneficial
Owner (or former Beneficial Owner) or Affiliates or Associates thereof as the Company shall reasonably request. Thereupon, the
Rights Agent shall, subject to Section 4(b), Section 7(e), Section 14, and Section 24 hereof, countersign and deliver to the Person
entitled thereto a Rights Certificate or Rights Certificates, as the case may be, as so requested. The Company may require payment
of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer, split up, combination,
or exchange of Rights Certificates.
(b) Upon
receipt by the Company and the Rights Agent of evidence reasonably satisfactory to them of the loss, theft, destruction, or mutilation
of a Rights Certificate, and, in case of loss, theft, or destruction, of indemnity or security reasonably satisfactory to them,
and reimbursement to the Company and the Rights Agent of all reasonable expenses incidental thereto, and upon surrender to the
Rights Agent and cancellation of the Rights Certificate if mutilated, the Company will execute and deliver a new Rights Certificate
of like tenor to the Rights Agent for countersignature and delivery to the registered holder in lieu of the Rights Certificate
so lost, stolen, destroyed, or mutilated.
Section 7.
Exercise
of Rights; Purchase Price; Expiration Date of Rights.
(a) Subject
to Section 7(e) hereof, at any time after the Distribution Date, the registered holder of any Rights Certificate may
exercise the Rights evidenced thereby (except as otherwise provided herein including, without limitation, the restrictions on
exercisability set forth in Section 9(c), Section 11(a)(iii), and Section 23(a) hereof) in whole or in part at any time after
the Distribution Date upon surrender of the Rights Certificate, with the form of election to purchase and the certificate on
the reverse side thereof duly executed, to the Rights Agent at the principal office or offices of the Rights Agent designated
for such purpose, together with payment of the aggregate Purchase Price with respect to the total number of shares (or other
securities, cash or other assets, as the case may be) as to which such surrendered Rights are then exercisable, at or prior
to the expiration of the Rights, which shall occur at the earlier of (i) 5:00 P.M. New York City time on April
__,
2020,
the date that is the third anniversary of the adoption of this Agreement, or such later date as may be
established by the Board of Directors prior to the expiration of the Rights (such date, as it may be extended by the Board,
the “
Final Expiration Date
”), (ii) the time at which the Rights are redeemed as provided in Section 23, or
(iii) the time at which the Rights may be exchanged as provided in Section 24 hereof (the earliest of (i), (ii), and (iii)
being herein referred to as the “
Expiration Date
”).
(b) The
Purchase Price for each share of Common Stock pursuant to the exercise of a Right shall initially be $26.80 (which Purchase Price
shall be based on the current trading price of the Company’s Common Stock), and shall be subject to adjustment from time
to time as provided in Sections 11 and 13(a) hereof and shall be payable in accordance with paragraph (c) below.
(c) Subject
to Section 7(e), upon receipt of a Rights Certificate representing exercisable Rights, with the form of election to purchase and
the certificate duly completed and executed, accompanied by payment, with respect to each Right so exercised, of the Purchase
Price per share of Common Stock (or other, securities, cash, or other assets, as the case may be) to be purchased as set forth
below and an amount equal to any applicable transfer tax, the Rights Agent shall, subject to Section 20(j) hereof, thereupon promptly
(i) (A) requisition from any transfer agent of the shares of Common Stock (or make available, if the Rights Agent is the transfer
agent for such shares) certificates for the total number of shares of Common Stock to be purchased and the Company hereby irrevocably
authorizes its transfer agent to comply with all such requests, or (B) if the Company shall have elected to deposit the total
number of shares of Common Stock issuable upon exercise of the Rights hereunder with a depositary agent, requisition from the
depositary agent depositary receipts representing such number of shares of Common Stock as are to be purchased (in which case,
certificates for the shares of Common Stock represented by such receipts shall be deposited by the transfer agent with the depositary
agent) and the Company will direct the depositary agent to comply with such request; (ii) requisition from the Company the amount
of cash, if any, to be paid in lieu of fractional shares in accordance with Section 14 hereof; (iii) after receipt of such certificates
or depositary receipts, cause the same to be delivered to or upon the order of the registered holder of such Rights Certificate,
registered in such name or names as may be designated by such holder; and (iv) after receipt thereof, deliver such cash, if any,
to or upon the order of the registered holder of such Rights Certificate. The payment of the Purchase Price (as such amount may
be reduced pursuant to Section 11(a)(iii) hereof) shall be made in cash or by certified bank check or bank draft payable to the
order of the Company. In the event that the Company is obligated to issue other securities of the Company, pay cash, and/or distribute
other property pursuant to Section 11(a) hereof, the Company will make all arrangements necessary so that such other securities,
cash, and/or other property are available for distribution by the Rights Agent, if and when appropriate. The Company reserves
the right to require prior to the occurrence of a Triggering Event that, upon any exercise of Rights, a number of Rights be exercised
so that only whole shares of Common Stock would be issued.
(d) In
case the registered holder of any Rights Certificate shall exercise less than all the Rights evidenced thereby, a new Rights Certificate
evidencing Rights equivalent to the Rights remaining unexercised shall be issued by the Rights Agent and delivered to, or upon
the order of, the registered holder of such Rights Certificate, registered in such name or names as may be designated by such
holder, subject to the provisions of Section 14 hereof.
(e) Notwithstanding
anything in this Agreement to the contrary, from and after the first occurrence of a Section 11(a)(ii) Event, any Rights beneficially
owned by (i) an Acquiring Person or an Associate or Affiliate of an Acquiring Person, (ii) a transferee of an Acquiring Person
(or of any Associate or Affiliate of an Acquiring Person) who becomes a transferee after the Acquiring Person becomes such, or
(iii) a transferee of an Acquiring Person (or of any such Associate or Affiliate) who becomes a transferee prior to or concurrently
with the Acquiring Person becoming such and receives such Rights pursuant to either (A) a transfer (whether or not for consideration)
from the Acquiring Person to holders of equity interests in such Acquiring Person or to any Person with whom the Acquiring Person
has any continuing agreement, arrangement, or understanding (whether or not in writing) regarding the transferred Rights, or (B)
a transfer which the Board has determined is part of a plan, arrangement, or understanding which has as a primary purpose or effect
the avoidance of this Section 7(e), shall become null and void without any further action and no holder of such Rights shall have
any rights whatsoever with respect to such Rights, whether under any provision of this Agreement or otherwise. The Company shall
use all reasonable efforts to insure that the provisions of this Section 7(e) and Section 4(b) hereof are complied with, but shall
have no liability to any holder of Rights Certificates or other Person as a result of its failure to make any determinations with
respect to an Acquiring Person or its Affiliates, Associates, or their respective transferees hereunder.
(f) Notwithstanding
anything in this Agreement to the contrary, neither the Rights Agent nor the Company shall be obligated to undertake any action
with respect to a registered holder upon the occurrence of any purported exercise as set forth in this Section 7 unless such registered
holder shall have (i) completed and signed the certificate contained in the form of election to purchase set forth on the reverse
side of the Rights Certificate surrendered for such exercise, and (ii) provided such additional evidence of the identity of the
Beneficial Owner (or former Beneficial Owner) or Affiliates or Associates thereof as the Company shall reasonably request.
Section 8.
Cancellation
and Destruction of Rights Certificates.
All Rights Certificates surrendered for the purpose of exercise, transfer, split up,
combination, redemption or exchange shall, if surrendered to the Company or any of its agents, be delivered to the Rights Agent
for cancellation or in cancelled form, or, if surrendered to the Rights Agent, shall be cancelled by it, and no Rights Certificates
shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall deliver
to the Rights Agent for cancellation and retirement, and the Rights Agent shall so cancel and retire, any other Rights Certificate
purchased or acquired by the Company otherwise than upon the exercise thereof. The Rights Agent shall deliver all cancelled Rights
Certificates to the Company, or shall, at the written request of the Company, destroy such cancelled Rights Certificates, and
in such case shall deliver a certificate of destruction thereof to the Company.
Section 9.
Reservation
and Availability of Capital Stock.
(a) The
Company covenants and agrees that it will cause to be reserved and kept available out of its authorized and unissued shares of
Common Stock, the number of shares of Common Stock (and, following the occurrence of a Triggering Event, Common Stock and/or other
securities) that, as provided in this Agreement including Section 11(a)(iii) hereof, will be sufficient to permit the exercise
in full of all outstanding Rights. Upon the occurrence of any events resulting in an increase in the aggregate number of shares
of Common Stock (or other securities of the Company, as the case may be) issuable upon exercise of all outstanding Rights above
the number then reserved, the Company shall use commercially reasonable best efforts to make appropriate increases in the number
of shares so reserved.
(b) The
Company further covenants and agrees that it will pay when due and payable any and all federal and state transfer taxes and charges
which may be payable in respect of the issuance or delivery of the Rights Certificates and of any certificates for a number of
shares of Common Stock (or other securities, as the case may be) upon the exercise of Rights. The Company shall not, however,
be required to pay any transfer tax which may be payable in respect of any transfer or delivery of Rights Certificates to a Person
other than, or the issuance or delivery of a number of shares of Common Stock (or other securities, as the case may be) in respect
of a name other than that of, the registered holder of the Rights Certificates evidencing Rights surrendered for exercise or to
issue or deliver any certificates for a number of shares of Common Stock (or other securities, as the case may be) in a name other
than that of the registered holder upon the exercise of any Rights until such tax shall have been paid (any such tax being payable
by the holder of such Rights Certificate at the time of surrender) or until it has been established to the Company’s satisfaction
that no such tax is due.
(c) The
Company may temporarily suspend, for a period of time not to exceed ninety days after the earliest date after the first occurrence
of a Section 11(a)(ii) Event on which the consideration to be delivered by the Company upon exercise of the Rights has been determined
in accordance with Section 11(a)(iii) hereof, the exercisability of the Rights in order to prepare and file a registration statement
relating to the securities purchasable upon exercise of the Rights on an appropriate form and permit it to become effective. Upon
any such suspension, the Company shall issue a public announcement stating that the exercisability of the Rights has been temporarily
suspended, as well as a public announcement at such time as the suspension is no longer in effect. In addition, if the Company
shall determine that a registration statement is required following the Distribution Date, the Company may temporarily suspend
the exercisability of the Rights until such time as a registration statement has been declared effective. Notwithstanding any
provision of this Agreement to the contrary, the Rights shall not be exercisable in any jurisdiction if the requisite qualification
in such jurisdiction shall not have been obtained, the exercise thereof shall not be permitted under applicable law, or a registration
statement shall not have been declared effective.
Section 10.
Common
Stock Record Date.
Each Person in whose name any certificate for a number of shares of Common Stock (or other securities,
as the case may be) is issued upon the exercise of Rights shall for all purposes be deemed to have become the holder of record
of such shares of Common Stock (or other securities, as the case may be) represented thereby on, and such certificate shall be
dated, the date upon which the Rights Certificate evidencing such Rights was duly surrendered and payment of the Purchase Price
(and all applicable transfer taxes) was made; provided, however, that if the date of such surrender and payment is a date upon
which the Common Stock (or other securities, as the case may be) transfer books of the Company are closed, such Person shall be
deemed to have become the record holder of such shares on, and such certificate shall be dated, the next succeeding Business Day
on which the Common Stock (or other securities, as the case may be) transfer books of the Company are open. Prior to the exercise
of the Rights evidenced thereby, the holder of a Rights Certificate shall not be entitled to any rights of a stockholder of the
Company with respect to shares for which the Rights shall be exercisable, including, without limitation, the right to vote, to
receive dividends or other distributions, or to exercise any preemptive rights, and shall not be entitled to receive any notice
of any proceedings of the Company, except as provided herein.
Section 11.
Adjustment
of Purchase Price, Number and Kind of Shares or Number of Rights.
The Purchase Price, the number and kind of shares covered
by each Right, and the number of Rights outstanding are subject to adjustment from time to time as provided in this Section 11.
(a) (i) In
the event the Company shall at any time after the date of this Agreement (A) declare a dividend on the Common Stock payable in
shares of Common Stock, (B) subdivide or split the outstanding Common Stock, (C) combine or consolidate the outstanding Common
Stock into a smaller number of shares, including a reverse stock split or otherwise or (D) issue any shares of its capital stock
in a reclassification of the Common Stock (including any such reclassification in connection with a consolidation or merger in
which the Company is the continuing or surviving corporation), except as otherwise provided in this Section 11(a) and Section
7(e) hereof, the Purchase Price in effect at the time of the record date for such dividend or of the effective date of such subdivision,
combination, split, consolidation or reclassification, and the number and kind of shares of Common Stock or capital stock, as
the case may be, issuable on such date, shall be proportionately adjusted so that the holder of any Right exercised after such
time shall be entitled to receive, upon payment of the Purchase Price then in effect, the aggregate number and kind of shares
of Common Stock or capital stock, as the case may be, which, if such Right had been exercised immediately prior to such date and
at a time when the Common Stock transfer books of the Company were open, such holder would have owned upon such exercise and been
entitled to receive by virtue of such dividend, subdivision, split, combination, or reclassification. If an event occurs which
would require an adjustment under both this Section 11(a)(i) and Section 11(a)(ii) hereof, the adjustment provided for in this
Section 11(a)(i) shall be in addition to, and shall be made prior to, any adjustment required pursuant to Section 11(a)(ii) hereof.
(ii) Subject
to Section 24 hereof, in the event any Person shall, at any time after the Rights Dividend Declaration Date, become an Acquiring
Person, unless the event causing such Person to become an Acquiring Person is a transaction set forth in Section 13(a) hereof,
then, promptly following the occurrence of such an event, proper provision shall be made so that each holder of a Right (except
as provided below and in Section 7(e) hereof) shall thereafter have the right to receive, upon exercise thereof at the then current
Purchase Price in accordance with the terms of this Agreement, in lieu of a number of shares of Common Stock into which a Right
was exercisable immediately prior to the first occurrence of a “Section 11(a)(ii) Event,” such number of shares of
Common Stock of the Company as shall equal the result obtained by (x) multiplying the then current Purchase Price by the then-number
of shares of Common Stock for which a Right was exercisable immediately prior to the first occurrence of a Section 11(a)(ii) Event,
and (y) dividing that product (which, following such first occurrence, shall thereafter be referred to as the “Purchase
Price” for each Right and for all purposes of this Agreement) by fifty percent of the Current Market Price (determined pursuant
to Section 11(d) hereof) per share of Common Stock on the date of such first occurrence (such number of shares, the “
Adjustment
Shares
”).
(iii) In
the event that the number of shares of Common Stock which are authorized by the Company’s Certificate of Incorporation,
as may be amended from time to time, but not outstanding or reserved for issuance for purposes other than upon exercise of the
Rights are not sufficient to permit the exercise in full of the Rights in accordance with the foregoing subparagraph (ii) of this
Section 11(a), the Company shall (A) determine the value of the Adjustment Shares issuable upon the exercise of a Right (the “
Current
Value
”), and (B) with respect to each Right (subject to Section 7(e) hereof), make adequate provision to substitute
for the Adjustment Shares, upon the exercise of a Right and payment of the applicable Purchase Price, (1) cash; (2) a reduction
in the Purchase Price; (3) other equity securities of the Company (including, without limitation, shares, or units of shares,
of preferred stock, which the Board has deemed to have essentially the same value or economic rights as shares of Common Stock
(such shares of equity securities being referred to as “
Common Stock Equivalents
”), (4) debt securities of
the Company; (5) other assets; or (6) any combination of the foregoing, having an aggregate value equal to the Current Value (less
the amount of any reduction in the Purchase Price), where such aggregate value has been determined by the Board based upon the
advice of a nationally recognized investment banking firm selected by the Board; provided, however, that if the Company shall
not have made adequate provision to deliver value pursuant to clause (B) above within thirty days following the later of (x) the
first occurrence of a Section 11(a)(ii) Event and (y) the date on which the Company’s right of redemption pursuant to Section
23(a) expires (the later of (x) and (y) being referred to herein as the “
Section 11(a)(ii) Trigger Date
”),
then the Company shall be obligated to deliver, upon the surrender for exercise of a Right and without requiring payment of the
Purchase Price, shares of Common Stock (to the extent available) and then, if necessary, cash, which shares and/or cash have an
aggregate value equal to the Spread. For purposes of the preceding sentence, the term “
Spread
” shall mean the
excess of (i) the Current Value over (ii) the Purchase Price. If the Board determines in good faith that it is likely that sufficient
additional shares of Common Stock could be authorized for issuance upon exercise in full of the Rights, the thirty day period
set forth above may be extended to the extent necessary, but not more than ninety days after the Section 11(a)(ii) Trigger Date,
in order that the Company may seek stockholder approval for the authorization of such additional shares (such thirty day period,
as it may be extended, is herein called the “
Substitution Period
”). To the extent that action is to be taken
pursuant to the first and/or third sentences of this Section 11(a)(iii), the Company (1) shall provide, subject to Section 7(e)
hereof, that such action shall apply uniformly to all outstanding Rights, and (2) may suspend the exercisability of the Rights
until the expiration of the Substitution Period in order to seek such stockholder approval for such authorization of additional
shares and/or to decide the appropriate form of distribution to be made pursuant to such first sentence and to determine the value
thereof. In the event of any such suspension, the Company shall issue a public announcement stating that the exercisability of
the Rights has been temporarily suspended, as well as a public announcement at such time as the suspension is no longer in effect.
For purposes of this Section 11(a)(iii), the value of each Adjustment Share shall be the Current Market Price per share of the
Common Stock on the Section 11(a)(ii) Trigger Date and the per-share or per-unit value of any Common Stock Equivalent shall be
deemed to equal the Current Market Price per share of the Common Stock on such date.
(b) In
case the Company shall fix a record date for the issuance of rights, options, or warrants to all holders of Common Stock entitling
them to subscribe for or purchase (for a period expiring within forty-five calendar days after such record date) Common Stock
(or shares having the same rights, privileges, and preferences as the shares of Common Stock (“
equivalent common stock
”))
or securities convertible into Common Stock, or equivalent common stock, at a price per share of Common Stock or per share of
equivalent common stock (or having a conversion price per share, if a security convertible into Common Stock or equivalent common
stock) less than the Current Market Price (as determined pursuant to Section 11(d) hereof) per share of Common Stock on such record
date, the Purchase Price to be in effect after such record date shall be determined by multiplying the Purchase Price in effect
immediately prior to such record date by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding
on such record date, plus the number of shares of Common Stock which the aggregate offering price of the total number of shares
of Common Stock and/or equivalent common stock so to be offered (and/or the aggregate initial conversion price of the convertible
securities so to be offered) would purchase at such Current Market Price, and the denominator of which shall be the number of
shares of Common Stock outstanding on such record date, plus the number of additional shares of Common Stock and/or equivalent
common stock to be offered for subscription or purchase (or into which the convertible securities so to be offered are initially
convertible). In case such subscription price may be paid by delivery of consideration part or all of which may be in a form other
than cash, the value of such consideration shall be as determined in good faith by the Board, whose determination shall be described
in a statement filed with the Rights Agent and shall be binding on the Rights Agent and the holders of the Rights. Shares of Common
Stock owned by or held for the account of the Company shall not be deemed outstanding for the purpose of any such computation.
Such adjustment shall be made successively whenever such a record date is fixed, and in the event that such rights or warrants
are not so issued, the Purchase Price shall be adjusted to be the Purchase Price which would then be in effect if such record
date had not been fixed.
(c) In
case the Company shall fix a record date for a distribution to all holders of Common Stock (including any such distribution made
in connection with a consolidation or merger in which the Company is the continuing or surviving corporation) of evidences of
indebtedness, cash (other than a regular quarterly cash dividend out of the earnings or retained earnings of the Company), assets
(other than a dividend payable in Common Stock, but including any dividend payable in stock other than Common Stock), or subscription
rights or warrants (excluding those referred to in Section 11(b) hereof), the Purchase Price to be in effect after such record
date shall be determined by multiplying the Purchase Price in effect immediately prior to such record date by a fraction, the
numerator of which shall be the Current Market Price (as determined pursuant to Section 11(d) hereof) per share of Common Stock
on such record date, less the fair market value (as determined in good faith by the Board, whose determination shall be described
in a statement filed with the Rights Agent) of the portion of the cash, assets, or evidences of indebtedness so to be distributed
or of such subscription rights or warrants applicable to a share of Common Stock and the denominator of which shall be such Current
Market Price (as determined pursuant to Section 11(d) hereof) per share of Common Stock. Such adjustments shall be made successively
whenever such a record date is fixed, and in the event that such distribution is not so made, the Purchase Price shall be adjusted
to be the Purchase Price which would have been in effect if such record date had not been fixed.
(d) For
the purpose of any computation hereunder, other than computations made pursuant to Section 11(a)(iii) hereof, the Current Market
Price per share of Common Stock on any date shall be deemed to be the average of the daily closing prices per share of such Common
Stock for the thirty consecutive Trading Days immediately prior to but not including such date, and for purposes of computations
made pursuant to Section 11(a)(iii) hereof, the Current Market Price per share of Common Stock on any date shall be deemed to
be the average of the daily closing prices per share of such Common Stock for the ten consecutive Trading Days immediately following
but not including such date; provided, however, that in the event that the Current Market Price per share of the Common Stock
is determined during a period following the announcement by the issuer of such Common Stock of (A) a dividend or distribution
on such Common Stock payable in shares of such Common Stock or securities convertible into shares of such Common Stock (other
than the Rights), or (B) any subdivision, combination, consolidation, reverse stock split or reclassification of such Common Stock,
and the ex-dividend date for such dividend or distribution, or the record date for such subdivision, combination, reverse stock
split, or reclassification shall not have occurred prior to the commencement of the requisite thirty Trading Day or ten Trading
Day period, as set forth above, then, and in each such case, the Current Market Price shall be properly adjusted to take into
account ex-dividend trading. The closing price for each day shall be the last sale price, regular way, or, in case no such sale
takes place on such day, the average of the closing bid and asked prices, regular way, in either case as reported in the principal
consolidated transaction reporting system with respect to securities listed or admitted to trading on the Nasdaq Stock Market
(“Nasdaq”) or, if the Common Stock is not listed or admitted to trading on the Nasdaq, as reported in the principal
consolidated transaction reporting system with respect to securities listed on the principal national securities exchange on which
the Common Stock is listed or admitted to trading or, if the Common Stock is not listed or admitted to trading on any national
securities exchange, the last quoted price or, if not so quoted, the average of the high bid and low asked prices in the over-the-counter
market, as reported on a quotation system then in use, or, if on any such date the Common Stock is not so quoted, the average
of the closing bid and asked prices as furnished by a professional market maker making a market in the Common Stock selected by
the Board. If on any such date no market maker is making a market in the Common Stock, the fair value of such shares on such date
as determined in good faith by the Board shall be used. The term “
Trading Day
” shall mean a day on which the
principal national securities exchange on which the shares of Common Stock are listed or admitted to trading is open for the transaction
of business or, if the shares of Common Stock are not listed or admitted to trading on any national securities exchange, a Business
Day. If the Common Stock is not publicly held or not so listed or traded, Current Market Price per share shall mean the fair value
per share as determined in good faith by the Board, whose determination shall be described in a statement filed with the Rights
Agent and shall be conclusive for all purposes.
(e) Anything
herein to the contrary notwithstanding, no adjustment in the Purchase Price shall be required unless such adjustment would require
an increase or decrease of at least one percent in the Purchase Price; provided, however, that any adjustments which by reason
of this Section 11(e) are not required to be made shall be carried forward and taken into account in any subsequent adjustment.
All calculations under this Section 11 shall be made to the nearest cent or to the nearest one-hundredth of a share of Common
Stock. Notwithstanding the first sentence of this Section 11(e), any adjustment required by this Section 11 shall be made no later
than the earlier of (i) three years from the date of the transaction which mandates such adjustment, or (ii) the Expiration Date.
(f) If,
as a result of an adjustment made pursuant to Section 11(a)(ii) or Section 13(a) hereof, the holder of any Right thereafter exercised
shall become entitled to receive any shares of capital stock other than Common Stock; thereafter, the number of such other shares
so receivable upon exercise of any Right and the Purchase Price thereof shall be subject to adjustment from time to time in a
manner and on terms as nearly equivalent as practicable to the provisions with respect to the Common Stock contained in Sections
11(a), (b), (c), (e), (g), (h), (i), (j), (k), and (m), and the provisions of Sections 7, 9, 10, 13, and 14 hereof with respect
to the Common Stock shall apply on like terms to any such other shares.
(g) All
Rights originally issued by the Company subsequent to any adjustment made to the Purchase Price hereunder shall evidence the right
to purchase, at the adjusted Purchase Price, the number of shares of Common Stock purchasable from time to time hereunder upon
exercise of the Rights, all subject to further adjustment as provided herein.
(h) Unless
the Company shall have exercised its election as provided in Section 11(i), upon each adjustment of the Purchase Price as a result
of the calculations made in Sections 11(b) and (c), each Right outstanding immediately prior to the making of such adjustment
shall thereafter evidence the right to purchase, at the adjusted Purchase Price, that number of shares of Common Stock obtained
by (i) multiplying (x) the number of shares covered by a Right immediately prior to this adjustment by (y) the Purchase Price
in effect immediately prior to such adjustment of the Purchase Price, and (ii) dividing the product so obtained by the Purchase
Price in effect immediately after such adjustment of the Purchase Price.
(i) The
Company may elect on or after the date of any adjustment of the Purchase Price to adjust the number of Rights, in lieu of any
adjustment in the number of shares of Common Stock purchasable upon the exercise of a Right. Each of the Rights outstanding after
the adjustment in the number of Rights shall be exercisable for the number of shares of Common Stock for which a Right was exercisable
immediately prior to such adjustment. Each Right held of record prior to such adjustment of the number of Rights shall become
that number of Rights (calculated to the nearest one-hundredth) obtained by dividing the Purchase Price in effect immediately
prior to adjustment of the Purchase Price by the Purchase Price in effect immediately after adjustment of the Purchase Price.
The Company shall make a public announcement of its election to adjust the number of Rights, indicating the record date for the
adjustment, and, if known at the time, the amount of the adjustment to be made. This record date may be the date on which the
Purchase Price is adjusted or any day thereafter, but, if the Rights Certificates have been issued, shall be at least ten days
later than the date of the public announcement. If Rights Certificates have been issued, upon each adjustment of the number of
Rights pursuant to this Section 11(i), the Company shall, as promptly as practicable, cause to be distributed to holders of record
of Rights Certificates on such record date Rights Certificates evidencing, subject to Section 14 hereof, the additional Rights
to which such holders shall be entitled as a result of such adjustment, or, at the option of the Company, shall cause to be distributed
to such holders of record in substitution and replacement for the Rights Certificates held by such holders prior to the date of
adjustment, and upon surrender thereof, if required by the Company, new Rights Certificates evidencing all the Rights to which
such holders shall be entitled after such adjustment. Rights Certificates so to be distributed shall be issued, executed, and
countersigned in the manner provided for herein (and may bear, at the option of the Company, the adjusted Purchase Price) and
shall be registered in the names of the holders of record of Rights Certificates on the record date specified in the public announcement.
(j) Irrespective
of any adjustment or change in the Purchase Price or the number of shares of Common Stock issuable upon the exercise of the Rights,
the Rights Certificates theretofore and thereafter issued may continue to express the Purchase Price per share and the number
of shares which were expressed in the initial Rights Certificates issued hereunder.
(k) Before
taking any action that would cause an adjustment reducing the Purchase Price below the then stated value, if any, of the number
of shares of Common Stock issuable upon exercise of the Rights, the Company shall take any corporate action which may, in the
opinion of its counsel, be necessary in order that the Company may validly and legally issue fully paid and nonassessable such
number of shares of Common Stock at such adjusted Purchase Price.
(l) In
any case in which this Section 11 shall require that an adjustment in the Purchase Price be made effective as of a record date
for a specified event and a holder of any Right shall exercise such Right after such record date, but before the occurrence of
such event, the Company may elect to defer, until the occurrence of such event, the issuance to such exercising holder of such
number of shares of Common Stock and other capital stock or securities of the Company, if any, issuable upon such exercise which
are over and above the number of shares of Common Stock and other capital stock or securities of the Company, if any, issuable
upon such exercise on the basis of the Purchase Price in effect prior to such adjustment; provided, however, that the Company
shall deliver to such holder a due bill or other appropriate instrument evidencing such holder’s right to receive such additional
shares (fractional or otherwise) or securities upon the occurrence of the event requiring such adjustment.
(m) Anything
in this Section 11 to the contrary notwithstanding, the Company shall be entitled to make such reductions in the Purchase Price,
in addition to those adjustments expressly required by this Section 11, as and to the extent that, in their good faith judgment,
the Board shall determine to be advisable in order that any (i) consolidation or subdivision of the Common Stock; (ii) issuance
wholly for cash of any shares of Common Stock at less than the Current Market Price; (iii) issuance wholly for cash of shares
of Common Stock or securities which by their terms are convertible into or exchangeable for shares of preferred Stock; (iv) stock
dividends; or (v) issuance of rights, options, or warrants referred to in this Section 11, in each case hereafter made by the
Company to holders of its Common Stock, shall not be taxable to such stockholders.
(n) The
Company covenants and agrees that, after the Distribution Date, it will not, except as permitted by Section 23 or Section 27 hereof,
take (or permit any Subsidiary to take) any action if, at the time such action is taken, it is reasonably foreseeable that such
action will diminish substantially or otherwise eliminate the benefits intended to be afforded by the Rights.
(o) Anything
in this Agreement to the contrary notwithstanding, in the event that the Company shall at any time after the Rights Dividend Declaration
Date and prior to the Distribution Date (i) declare a dividend on the outstanding shares of Common Stock payable in shares of
Common Stock, (ii) subdivide the outstanding shares of Common Stock, or (iii) combine the outstanding shares of Common Stock
into a smaller number of shares, the number of Rights associated with each share of Common Stock then outstanding, or issued or
delivered thereafter but prior to the Distribution Date, shall be proportionately adjusted so that the number of Rights thereafter
associated with each share of Common Stock following any such event shall equal the result obtained by multiplying the number
of Rights associated with each share of Common Stock immediately prior to such event by a fraction, the numerator of which shall
be the total number of shares of Common Stock outstanding immediately prior to the occurrence of the event, and the denominator
of which shall be the total number of shares of Common Stock outstanding immediately following the occurrence of such event.
Section 12.
Certificate
of Adjusted Purchase Price or Number of Shares.
Whenever an adjustment is made or any event affecting the Rights or their
exercisability (including without limitation an event which causes Rights to become null and void) occurs as provided in Section
11 and Section 13 hereof, the Company shall (a) promptly prepare a certificate setting forth such adjustment or describing such
event, and a brief, reasonably detailed statement of the facts, computations and methodology accounting for such adjustment; (b)
promptly file with the Rights Agent, and with each transfer agent for the Common Stock, a copy of such certificate; and (c) if
a Distribution Date has occurred, mail a brief summary thereof to each holder of a Rights Certificate in accordance with Section
25 hereof. Notwithstanding the foregoing sentence, the failure of the Company to make such certification or give such notice shall
not affect the validity of such adjustment or the force or effect of the requirement for such adjustment. The Rights Agent shall
be fully protected in relying on any such certificate and on any adjustment or statement therein contained and shall have no duty
or liability with respect to, and shall not be deemed to have knowledge of, any adjustment or any such event unless and until
it shall have received such a certificate.
Section 13.
Consolidation,
Merger, or Sale or Transfer of Assets, Cash Flow, or Earning Power.
(a) In
the event that, following the Stock Acquisition Date, directly or indirectly, (x) the Company shall consolidate with, or merge
with and into, any other Person (other than a Subsidiary of the Company in a transaction which complies with Section 11(n) hereof),
and the Company shall not be the continuing or surviving corporation of such consolidation or merger; (y) any Person (other than
a Subsidiary of the Company in a transaction which complies with Section 11(n) hereof) shall consolidate with, or merge with or
into, the Company, and the Company shall be the continuing or surviving corporation of such consolidation or merger and, in connection
with such consolidation or merger, all or part of the outstanding shares of Common Stock shall be changed into or exchanged for
stock or other securities of any other Person or cash or any other property; or (z) the Company shall sell or otherwise transfer
(or one or more of its Subsidiaries shall sell or otherwise transfer), in one transaction or a series of related transactions,
assets, cash flow, or earning power aggregating more than fifty percent of the assets, cash flow, or earning power of the Company
and its Subsidiaries (taken as a whole) to any Person or Persons (other than the Company or any Subsidiary of the Company in one
or more transactions each of which complies with Section 11(n) hereof), then, and in each such case, proper provision shall be
made so that: (i) each holder of a Right, except as provided in Section 7(e) hereof, shall thereafter have the right to receive,
upon the exercise thereof at the then-current Purchase Price in accordance with the terms of this Agreement, such number of validly
authorized and issued, fully paid, non-assessable, and freely tradeable shares of Common Stock of the Principal Party (as such
term is hereinafter defined), not subject to any liens, encumbrances, rights of first refusal, or other adverse claims, as shall
be equal to the result obtained by (1) multiplying the then-current Purchase Price by the number of shares of Common Stock for
which a Right is exercisable immediately prior to the first occurrence of a Section 13 Event (or, if a Section 11(a)(ii) Event
has occurred prior to the first occurrence of a Section 13 Event, multiplying the number of such shares for which a Right was
exercisable immediately prior to the first occurrence of a Section 11(a)(ii) Event by the Purchase Price in effect immediately
prior to such first occurrence of a Section 11(a)(ii) Event), and (2) dividing that product (which, following the first occurrence
of a Section 13 Event, shall be referred to as the “Purchase Price” for each Right and for all purposes of this Agreement)
by fifty percent of the Current Market Price (determined pursuant to Section 11(d)(i) hereof) per share of the Common Stock of
such Principal Party on the date of consummation of such Section 13 Event; (ii) such Principal Party shall thereafter be liable
for, and shall assume, by virtue of such Section 13 Event, all the obligations and duties of the Company pursuant to this Agreement;
(iii) the term “Company” shall thereafter be deemed to refer to such Principal Party, it being specifically intended
that the provisions of Section 11 hereof shall apply only to such Principal Party following the first occurrence of a Section
13 Event; (iv) such Principal Party shall take such steps (including, but not limited to, the reservation of a sufficient number
of shares of its Common Stock) in connection with the consummation of any such transaction as may be necessary to assure that
the provisions hereof shall thereafter be applicable, as nearly as reasonably may be, in relation to its shares of Common Stock
thereafter deliverable upon the exercise of the Rights; and (v) the provisions of Section 11(a)(ii) hereof shall be of no effect
following the first occurrence of any Section 13 Event.
(b) “
Principal
Party
” shall mean
(i) in
the case of any transaction described in clause (x) or (y) of the first sentence of Section 13(a), the Person that is the issuer
of any securities into which shares of Common Stock of the Company are converted in such merger or consolidation, and if no securities
are so issued, the Person that is the other party to such merger or consolidation; and
(ii) in
the case of any transaction described in clause (z) of the first sentence of Section 13(a), the Person that is the party receiving
the greatest portion of the assets, cash flow, or earning power transferred pursuant to such transaction or transactions;
provided, however, that in any such case,
(1) if the Common Stock of such Person is not at such time and has not been continuously over the preceding twelve month period
registered under Section 12 of the Exchange Act, and such Person is a direct or indirect Subsidiary of another Person the Common
Stock of which is and has been so registered, “Principal Party” shall refer to such other Person; and (2) in case
such Person is a Subsidiary, directly or indirectly, of more than one Person, the Common Stocks of two or more of which are and
have been so registered, “Principal Party” shall refer to whichever of such Persons is the issuer of the Common Stock
having the greatest aggregate market value.
(c) The
Company shall not consummate any such consolidation, merger, sale, or transfer unless the Principal Party shall have a sufficient
number of authorized shares of its Common Stock which have not been issued or reserved for issuance to permit the exercise in
full of the Rights in accordance with this Section 13 and unless prior thereto the Company and such Principal Party shall have
executed and delivered to the Rights Agent a supplemental agreement providing for the terms set forth in paragraphs (a) and (b)
of this Section 13 and further providing that, as soon as practicable after the date of any consolidation, merger, or sale of
assets mentioned in paragraph (a) of this Section 13, the Principal Party will:
(i) prepare
and file a registration statement under the Act, with respect to the Rights and the securities purchasable upon exercise of the
Rights on an appropriate form, and will use its best efforts to cause such registration statement to (A) become effective as soon
as practicable after such filing and (B) remain effective (with a prospectus at all times meeting the requirements of the Act)
until the Expiration Date; and
(ii) take
all such other action as may be necessary to enable the Principal Party to issue the securities purchasable upon exercise of the
Rights, including but not limited to the registration or qualification of such securities under all requisite securities laws
of jurisdictions of the various states and the listing of such securities on such exchanges and trading markets as may be necessary
or appropriate; and
(iii) deliver
to holders of the Rights historical financial statements for the Principal Party and each of its Affiliates which comply in all
respects with the requirements for registration on Form 10 under the Exchange Act.
The provisions of this
Section 13 shall similarly apply to successive mergers or consolidations or sales or other transfers. In the event that a Section
13 Event shall occur at any time after the occurrence of a Section 11(a)(ii) Event, the Rights which have not theretofore been
exercised shall thereafter become exercisable in the manner described in Section 13(a).
Section 14.
Fractional
Rights and Fractional Shares.
(a) The
Company shall not be required to issue fractions of Rights, except prior to the Distribution Date as provided in Section 11(o)
hereof, or to distribute Rights Certificates which evidence fractional Rights. In lieu of such fractional Rights, there shall
be paid to the registered holders of the Rights Certificates with regard to which such fractional Rights would otherwise be issuable,
an amount in cash equal to the same fraction of the current market value of a whole Right. For purposes of this Section 14(a),
the current market value of a whole Right shall be the closing price of the Rights for the Trading Day immediately prior to the
date on which such fractional Rights would have been otherwise issuable. The closing price of the Rights for any Trading Day shall
be the last sale price, regular way, or, in case no such sale takes place on such day, the average of the closing bid and asked
prices, regular way, in either case as reported in the principal consolidated transaction reporting system with respect to securities
listed or admitted to trading on the Nasdaq or, if the Rights are not listed or admitted to trading on the Nasdaq, as reported
in the principal consolidated transaction reporting system with respect to securities listed or admitted to trading on the principal
national securities exchange on which the Rights are listed or admitted to trading, or if the Rights are not listed or admitted
to trading on any national securities exchange, the last quoted price or, if not so quoted, the average of the high bid and low
asked prices in the over-the-counter market, as reported by a quotation system then in use or, if on any such date the Rights
are not so quoted, the average of the closing bid and asked prices as furnished by a professional market maker making a market
in the Rights, selected by the Board. If on any such date no such market maker is making a market in the Rights, the fair value
of the Rights on such date as determined in good faith by the Board shall be used.
(b) Following
the occurrence of a Triggering Event, the Company shall not be required to issue fractions of shares of Common Stock upon exercise
of the Rights or to distribute certificates which evidence fractional shares of Common Stock. In lieu of fractional shares of
Common Stock, the Company may pay to the registered holders of Rights Certificates at the time such Rights are exercised as herein
provided an amount in cash equal to the same fraction of the current market value of one (1) share of Common Stock. For purposes
of this Section 14(c), the current market value of one share of Common Stock shall be the closing price of one share of Common
Stock (as determined pursuant to Section 11(d)(i) hereof) for the Trading Day immediately prior to the date of such exercise.
(c) The
holder of a Right by the acceptance of the Rights expressly waives his right to receive any fractional Rights or any fractional
shares upon exercise of a Right, except as permitted by this Section 14.
Section 15.
Rights
of Action.
All rights of action in respect of this Agreement are vested in the respective registered holders of the Rights
Certificates (and, prior to the Distribution Date, the registered holders of the Common Stock); and any registered holder of any
Rights Certificate (or, prior to the Distribution Date, of the Common Stock), without the consent of the Rights Agent or of the
holder of any other Rights Certificate (or, prior to the Distribution Date, of the Common Stock), may, in such holder’s
own behalf and for such holder’s own benefit, enforce, and may institute and maintain any suit, action, or proceeding against
the Company to enforce, or otherwise act in respect of, such holder’s right to exercise the Rights evidenced by such Rights
Certificate in the manner provided in such Rights Certificate and in this Agreement. Without limiting the foregoing or any remedies
available to the holders of Rights, it is specifically acknowledged that the holders of Rights would not have an adequate remedy
at law for any breach of this Agreement and shall be entitled to specific performance of the obligations hereunder and injunctive
relief against actual or threatened violations of the obligations hereunder by any Person subject to this Agreement.
Section 16.
Agreement
of Rights Holders.
Every holder of a Right by accepting the same consents and agrees with the Company and the Rights Agent
and with every other holder of a Right that:
(a) prior
to the Distribution Date, the Rights will be transferable only in connection with the transfer of shares of Common Stock;
(b) after
the Distribution Date, the Rights Certificates are transferable only on the registry books of the Rights Agent if surrendered
at the principal office or offices of the Rights Agent designated for such purposes, duly endorsed or accompanied by a proper
instrument of transfer and with the appropriate forms and certificates fully executed;
(c) subject
to Section 6(a) and Section 7(f) hereof, the Company and the Rights Agent may deem and treat the Person in whose name a Rights
Certificate (or, prior to the Distribution Date, the associated Common Stock certificate) (or book entry shares in respect of
Common Stock) is registered as the absolute owner thereof and of the Rights evidenced thereby (notwithstanding any notations of
ownership or writing on the Rights Certificates or the associated Common Stock certificate (or notices provided to holders of
book entry shares of Common Stock) made by anyone other than the Company or the Rights Agent) for all purposes whatsoever, and
neither the Company nor the Rights Agent, subject to the last sentence of Section 7(e) hereof, shall be required to be affected
by any notice to the contrary; and
(d) notwithstanding
anything in this Agreement to the contrary, neither the Company nor the Rights Agent shall have any liability to any holder of
a Right or other Person as a result of its inability to perform any of its obligations under this Agreement by reason of any preliminary
or permanent injunction or other judgment, order, decree, or ruling issued by a court of competent jurisdiction or by a governmental,
regulatory, or administrative agency or commission, or any statute, rule, regulation, or executive order promulgated or enacted
by any governmental authority, prohibiting or otherwise restraining performance of such obligation; provided, however, the Company
must use its best efforts to have any such order, judgment, injunction, decree, or ruling lifted or otherwise overturned as soon
as possible.
Section 17.
Rights
Certificate Holder Not Deemed a Stockholder.
No holder, as such, of any Rights Certificate shall be entitled to vote, receive
dividends, or be deemed for any purpose the holder of the number of shares of Common Stock or any other securities of the Company
which may at any time be issuable on the exercise or exchange of the Rights represented thereby, nor shall anything contained
herein or in any Rights Certificate be construed to confer upon the holder of any Rights Certificate, as such, any of the rights
of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders
at any meeting thereof, or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions
affecting stockholders (except as provided in Section 24 hereof), or to receive dividends or subscription rights, or otherwise,
until the Right or Rights evidenced by such Rights Certificate shall have been exercised or exchanged in accordance with the provisions
hereof.
Section 18.
Concerning
the Rights Agent.
(a) The
Company agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder and, from time to
time, on demand of the Rights Agent, its reasonable expenses and counsel fees and disbursements and other disbursements incurred
in the administration and execution of this Agreement and the exercise and performance of its duties hereunder. The Company also
agrees to indemnify the Rights Agent, and any subsidiary or affiliate of the Rights Agent, and any director, officer, employee
or agent of the Rights Agent or any subsidiary or affiliate of the Rights Agent, for, and to hold each of them harmless against,
any loss, liability, damage, cost or expense, incurred without gross negligence, bad faith, or willful misconduct on the part
of the Rights Agent, for anything done or omitted by the Rights Agent or such other indemnified party in connection with the acceptance
and administration of this Agreement or the performance of the Rights Agent’s duties hereunder, including the costs and
expenses of defending against any claim of liability in the premises.
(b) The
Rights Agent shall be protected and shall incur no liability for or in respect of any action taken, suffered, or omitted by it
in connection with its administration of this Agreement or the performance of the Rights Agent’s duties hereunder in reliance
upon any Rights Certificate or certificate for Common Stock or for other securities of the Company, instrument of assignment or
transfer, power of attorney, endorsement, affidavit, letter, notice, direction, consent, certificate, statement, or other paper
or document believed by it to be genuine and to be signed, executed, and, where necessary, verified or acknowledged, by the proper
Person or Persons.
Section 19.
Merger
or Consolidation or Change of Name of Rights Agent.
(a) Any
Person into which the Rights Agent or any successor Rights Agent may be merged or with which it may be consolidated, or any Person
resulting from any merger or consolidation to which the Rights Agent or any successor Rights Agent shall be a party, or any Person
succeeding to the corporate trust, stock transfer or stockholder services business of the Rights Agent or any successor Rights
Agent, shall be the successor to the Rights Agent under this Agreement without the execution or filing of any paper or any further
act on the part of any of the parties hereto; provided, however, that such Person would be eligible for appointment as a successor
Rights Agent under the provisions of Section 21 hereof. In case at the time such successor Rights Agent shall succeed to the agency
created by this Agreement, any of the Rights Certificates shall have been countersigned but not delivered, any such successor
Rights Agent may adopt the countersignature of a predecessor Rights Agent and deliver such Rights Certificates so countersigned;
and in case at that time any of the Rights Certificates shall not have been countersigned, any successor Rights Agent may countersign
such Rights Certificates either in the name of the predecessor or in the name of the successor Rights Agent; and in all such cases
such Rights Certificates shall have the full force provided in the Rights Certificates and in this Agreement.
(b) In
case at any time the name of the Rights Agent shall be changed and at such time any of the Rights Certificates shall have been
countersigned but not delivered, the Rights Agent may adopt the countersignature under its prior name and deliver Rights Certificates
so countersigned; and in case at that time any of the Rights Certificates shall not have been countersigned, the Rights Agent
may countersign such Rights Certificates either in its prior name or in its changed name; and in all such cases such Rights Certificates
shall have the full force provided in the Rights Certificates and in this Agreement.
Section 20.
Duties
of Rights Agent.
The Rights Agent undertakes the duties and obligations imposed by this Agreement upon the following terms
and conditions, by all of which the Company and the holders of Rights Certificates, by their acceptance thereof, shall be bound:
(a) The
Rights Agent may consult with legal counsel of its selection (who may be legal counsel for the Company), and the written advice
or opinion of such counsel shall be full and complete authorization and protection to the Rights Agent as to any action taken
or omitted by it in good faith and in accordance with such written advice or opinion.
(b) Whenever
in the performance of its duties under this Agreement the Rights Agent shall deem it necessary or desirable that any fact or matter
(including, without limitation, the identity of any Acquiring Person and the determination of “Current Market Price”)
be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence
in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate
signed by the Chairman of the Board, the Chief Executive Officer, the President, any Vice President, the Treasurer, any Assistant
Treasurer, the Secretary, or any Assistant Secretary of the Company and delivered to the Rights Agent; and such certificate shall
be full authorization to the Rights Agent for any action taken or suffered in good faith by it under the provisions of this Agreement
in reliance upon such certificate.
(c) The
Rights Agent shall be liable hereunder only for its own gross negligence, bad faith, or willful misconduct.
(d) The
Rights Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or
in the Rights Certificates or be required to verify the same (except as to its countersignature on such Rights Certificates),
but all such statements and recitals are and shall be deemed to have been made by the Company only.
(e) The
Rights Agent shall not be under any responsibility in respect of the validity of this Agreement or the execution and delivery
hereof (except the due execution hereof by the Rights Agent) or in respect of the validity or execution of any Rights Certificate
(except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition
contained in this Agreement or in any Rights Certificate; nor shall it be responsible for any adjustment required under the provisions
of Section 11, Section 13, or Section 24 hereof or responsible for the manner, method, or amount of any such adjustment or
the ascertaining of the existence of facts that would require any such adjustment (except with respect to the exercise of Rights
evidenced by Rights Certificates after actual notice of any such adjustment); nor shall it by any act hereunder be deemed to make
any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this
Agreement or any Rights Certificate or as to whether any shares of Common Stock will, when so issued, be validly authorized and
issued, fully paid, and nonassessable.
(f) The
Company agrees that it will perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered
all such further and other acts, instruments, and assurances as may reasonably be required by the Rights Agent for the carrying
out or performing by the Rights Agent of the provisions of this Agreement.
(g) The
Rights Agent is hereby authorized and directed to accept instructions with respect to the performance of its duties hereunder
from the Chairman of the Board, the Chief Executive Officer, the President, any Vice President, the Secretary, any Assistant Secretary,
the Treasurer, or any Assistant Treasurer of the Company, and to apply to such officers for advice or instructions in connection
with its duties, and it shall not be liable for any action taken or suffered to be taken by it in good faith in accordance with
instructions of any such officer or for any delay in acting while awaiting instructions.
(h) The
Rights Agent and any stockholder, director, officer, or employee of the Rights Agent may buy, sell, or deal in any of the Rights
or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested,
or contract with or lend money to the Company or otherwise act as fully and freely as though it were not Rights Agent under this
Agreement. Nothing herein shall preclude the Rights Agent from acting in any other capacity for the Company or for any other legal
entity.
(i) The
Rights Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself
or by or through its attorneys or agents, and the Rights Agent shall not be answerable or accountable for any act, default, neglect,
or misconduct of any such attorneys or agents or for any loss to the Company resulting from any such act, default, neglect, or
misconduct; provided, however, reasonable care was exercised in the selection and continued employment thereof.
(j) If,
with respect to any Rights Certificate surrendered to the Rights Agent for exercise or transfer, the certificate attached to the
form of assignment or form of election to purchase, as the case may be, has either not been completed or indicates an affirmative
response to clause 1 and/or 2 thereof, the Rights Agent shall not take any further action with respect to such requested exercise
or transfer without first consulting with the Company.
Section 21.
Change
of Rights Agent.
The Rights Agent or any successor Rights Agent may resign and be discharged from its duties under this Agreement
upon thirty days’ notice in writing mailed to the Company, and to each transfer agent of the Common Stock, by registered
or certified mail, and, if such resignation occurs after the Distribution Date, to the registered holders of the Rights Certificates
by first-class mail. The Company may remove the Rights Agent or any successor Rights Agent upon thirty days’ notice in writing,
mailed to the Rights Agent or successor Rights Agent, as the case may be, and to each transfer agent of the Common Stock, by registered
or certified mail, and, if such removal occurs after the Distribution Date, to the holders of the Rights Certificates by first-class
mail. If the Rights Agent shall resign or be removed or shall otherwise become incapable of acting, the Company shall appoint
a successor to the Rights Agent. If the Company shall fail to make such appointment within a period of thirty days after giving
notice of such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated
Rights Agent or by the holder of a Rights Certificate (who shall, with such notice, submit his Rights Certificate for inspection
by the Company), then any registered holder of any Rights Certificate may apply to any court of competent jurisdiction for the
appointment of a new Rights Agent. Any successor Rights Agent, whether appointed by the Company or by such a court, shall be (a)
a corporation or other form of entity organized and doing business under the laws of the United States or of any of the states
of the United States, in good standing, which is authorized under such laws to exercise corporate trust powers and is subject
to supervision or examination by federal or state authority and which has at the time of its appointment as Rights Agent a combined
capital and surplus of at least $50,000,000 or (b) an affiliate of a corporation or other entity described in clause (a) of this
sentence. After appointment, the successor Rights Agent shall be vested with the same powers, rights, duties, and responsibilities
as if it had been originally named as Rights Agent without further act or deed; but the predecessor Rights Agent shall deliver
and transfer to the successor Rights Agent any property at the time held by it hereunder, and execute and deliver any further
assurance, conveyance, act, or deed necessary for the purpose. Not later than the effective date of any such appointment, the
Company shall file notice thereof in writing with the predecessor Rights Agent and each transfer agent of the Common Stock, and,
if such appointment occurs after the Distribution Date, mail a notice thereof in writing to the registered holders of the Rights
Certificates. Failure to give any notice provided for in this Section 21, however, or any defect therein, shall not affect the
legality or validity of the resignation or removal of the Rights Agent or the appointment of the successor Rights Agent, as the
case may be.
Section 22.
Issuance
of New Rights Certificates.
Notwithstanding any of the provisions of this Agreement or of the Rights to the contrary, the
Company may, at its option, issue new Rights Certificates evidencing Rights in such form as may be approved by its Board of Directors
to reflect any adjustment or change in the Purchase Price and the number or kind or class of shares or other securities or property
purchasable under the Rights Certificates made in accordance with the provisions of this Agreement. In addition, in connection
with the issuance or sale of shares of Common Stock following the Distribution Date and prior to the redemption or expiration
of the Rights, the Company (a) shall, with respect to shares of Common Stock so issued or sold pursuant to the exercise of stock
options or under any employee plan or arrangement, granted or awarded as of the Distribution Date, or upon the exercise, conversion,
or exchange of securities hereinafter issued by the Company, and (b) may, in any other case, if deemed necessary or appropriate
by the Board, issue Rights Certificates representing the appropriate number of Rights in connection with such issuance or sale;
provided, however, that (i) no such Rights Certificate shall be issued if, and to the extent that, the Company shall be advised
by counsel that such issuance would create a significant risk of material adverse tax consequences to the Company or the Person
to whom such Rights Certificate would be issued, and (ii) no such Rights Certificate shall be issued if, and to the extent that,
appropriate adjustment shall otherwise have been made in lieu of the issuance thereof.
Section 23.
Redemption
and Termination.
(a)
The
Board may, at its option, at any time prior to the earlier of (i) the close of business on the tenth Business Day following the
Stock Acquisition Date (or, if the Stock Acquisition Date shall have occurred prior to the Record Date, the close of business on
the tenth Business Day following the Record Date), or (ii) the Final Expiration Date, redeem all, but not less than all, of the
then-outstanding Rights at a redemption price of $0.001 per Right, as such amount may be appropriately adjusted to reflect
any stock split, stock dividend, or similar transaction occurring after the date hereof (such redemption price being hereinafter
referred to as the “
Redemption Price
”). The Company may, at its option, pay the Redemption Price in cash, shares
of Common Stock (based on the Current Market Price, of the Common Stock at the time of redemption), or any other form of consideration
deemed appropriate by the Board of Directors.
(b) Immediately
upon the action of the Board ordering the redemption of the Rights, evidence of which shall have been filed with the Rights Agent
and without any further action and without any notice, the right to exercise the Rights will terminate and the only right thereafter
of the holders of Rights shall be to receive the Redemption Price for each Right so held. Promptly after the action of the Board
of Directors ordering the redemption of the Rights, the Company shall give notice of such redemption to the Rights Agent and the
holders of the then-outstanding Rights by mailing such notice to all such holders at each holder’s last address as it appears
upon the registry books of the Rights Agent or, prior to the Distribution Date, on the registry books of the transfer agent for
the Common Stock. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the holder receives
the notice. Each such notice of redemption will state the method by which the payment of the Redemption Price will be made.
Section 24.
Exchange.
(a) The
Board may, at its option, at any time after any Person becomes an Acquiring Person, exchange all or part of the then-outstanding
and exercisable Rights (which shall not include Rights that have become void pursuant to the provisions of Section 7(e) hereof)
for Common Stock at an exchange ratio of one share of Common Stock per Right, appropriately adjusted to reflect any stock split,
stock dividend or similar transaction occurring after the date hereof (such exchange ratio being hereinafter referred to as the
“
Exchange Ratio
”). Notwithstanding the foregoing, the Board shall not be empowered to effect such exchange
at any time after (i) any Person (other than the Company, any Subsidiary of the Company, any employee benefit plan of the Company
or any such Subsidiary, or any entity holding Common Stock for or pursuant to the terms of any such plan), together with all Affiliates
and Associates of such Person, becomes the Beneficial Owner of fifty percent or more of the Common Stock then outstanding, or
(ii) the occurrence of an event specified in Section 13(a) hereof.
(b) Immediately
upon the action of the Board ordering the exchange of any Rights pursuant to subsection (a) of this Section 24 and without any
further action and without any notice, the right to exercise such Rights shall terminate and the only right thereafter of a holder
of such Rights shall be to receive that number of shares of Common Stock equal to the number of such Rights held by such holder
multiplied by the Exchange Ratio. The Company shall promptly give public notice of any such exchange; provided, however, that
the failure to give, or any defect in, such notice shall not affect the validity of such exchange. The Company promptly shall
mail a notice of any such exchange to all of the holders of such Rights at their last addresses as they appear upon the registry
books of the Rights Agent. Any notice which is mailed in the manner herein provided shall be deemed given, whether or not the
holder receives the notice. Each such notice of exchange will state the method by which the exchange of the Common Stock for Rights
will be effected and, in the event of any partial exchange, the number of Rights which will be exchanged. Any partial exchange
shall be effected pro rata based on the number of Rights (other than Rights which have become void pursuant to the provisions
of Section 7(e) hereof) held by each holder of Rights.
(c) In
the event that there shall not be sufficient shares of Common Stock issued but not outstanding or authorized but unissued to permit
any exchange of Rights as contemplated in accordance with this Section 24, the Company shall take all such action as may be necessary
to authorize additional shares of Common Stock for issuance upon exchange of the Rights.
(d) The
Company shall not be required to issue fractions of shares of Common Stock or to distribute certificates which evidence fractional
shares of Common Stock. In lieu of such fractional shares of Common Stock, there shall be paid to the registered holders of the
Rights Certificates with regard to which such fractional shares of Common Stock would otherwise be issuable, an amount in cash
equal to the same fraction of the current market value of a whole share of Common Stock. For the purposes of this subsection (e),
the current market value of a whole share of Common Stock shall be the closing price of a share of Common Stock (as determined
pursuant to the second sentence of Section 11(d)(i) hereof) for the Trading Day immediately prior to the date of exchange pursuant
to this Section 24.
Section 25.
Notice
of Certain Events.
(a) In
case the Company shall propose, at any time after the Distribution Date, (i) to pay any dividend payable in stock of any class
to the holders of Common Stock or to make any other distribution to the holders of Common Stock (other than a regular quarterly
cash dividend out of earnings or retained earnings of the Company); or (ii) to offer to the holders of Common Stock rights or
warrants to subscribe for or to purchase any additional shares of Common Stock or shares of stock of any class or any other securities,
rights, or options; or (iii) to effect any reclassification of its Common Stock (other than a reclassification involving
only the subdivision of outstanding shares of Common Stock); or (iv) to effect any consolidation or merger into or with any other
Person (other than a Subsidiary of the Company in a transaction that complies with Section 11(n) hereof), or to effect any sale
or other transfer (or to permit one or more of its Subsidiaries to effect any sale or other transfer), in one transaction or a
series of related transactions, of more than 50 percent of the assets, cash flow, or earning power of the Company and its Subsidiaries
(taken as a whole) to any other Person or Persons (other than the Company and/or any of its Subsidiaries in one or more transactions
each of which complies with Section 11(n) hereof); or (v) to effect the liquidation, dissolution, or winding up of the Company,
then, in each such case, the Company shall give to each holder of a Rights Certificate, to the extent feasible and in accordance
with Section 26 hereof, a notice of such proposed action, which shall specify the record date for the purposes of such stock dividend,
distribution of rights or warrants, or the date on which such reclassification, consolidation, merger, sale, transfer, liquidation,
dissolution, or winding up is to take place and the date of participation therein by the holders of the shares of Common Stock,
if any such date is to be fixed, and such notice shall be so given in the case of any action covered by clause (i) or (ii) above
at least twenty days prior to the record date for determining holders of the shares of Common Stock for purposes of such action,
and in the case of any such other action, at least twenty days prior to the date of the taking of such proposed action or the
date of participation therein by the holders of the shares of Common Stock, whichever shall be the earlier.
(b) In
the event that any Section 11(a)(ii) Event shall occur, the Company shall as soon as practicable thereafter give to each holder
of a Rights Certificate, to the extent feasible and in accordance with Section 26 hereof, a notice of the occurrence of such event,
which shall specify the event and the consequences of the event to holders of Rights under Section 11(a)(ii) hereof.
Section 26.
Notices
.
Notices or demands authorized by this Agreement to be given or made by the Rights Agent or by the holder of any Rights Certificate
to or on the Company shall be sufficiently given or made if sent by first-class mail, postage prepaid, addressed (until another
address is filed in writing with the Rights Agent) as follows:
|
Anavex Life Sciences Corp.
51 W 52
nd
Street, 7
th
Floor,
New York, NY USA
Attention: Secretary
|
Subject to the provisions of Section 21, any
notice or demand authorized by this Agreement to be given or made by the Company or by the holder of any Rights Certificate to
or on the Rights Agent shall be sufficiently given or made if sent by first-class mail, postage prepaid, addressed (until another
address is filed in writing with the Company) as follows:
|
________________
________________
________________
Attention:
|
Notices or demands authorized by this Agreement
to be given or made by the Company or the Rights Agent to the holder of any Rights Certificate (or, if prior to the Distribution
Date, to the holder of certificates representing shares of Common Stock) shall be sufficiently given or made if sent by first-class
mail, postage prepaid, addressed to such holder at the address of such holder as shown on the registry books of the Company.
Section 27.
Supplements
and Amendments.
Subject to this Section 27, this Agreement may be supplemented or amended at the times and for the purposes
set forth below. Prior to the Distribution Date, the Company and the Rights Agent shall, if the Company so directs, supplement
or amend any provision of this Agreement without the approval of any holders of shares of Common Stock. From and after the Distribution
Date, the Company and the Rights Agent shall, if the Company so directs, supplement or amend this Agreement without the approval
of any holders of Rights Certificates in order (i) to cure any ambiguity, (ii) to correct or supplement any provision contained
herein that may be defective or inconsistent with any other provisions herein, (iii) to shorten or lengthen any time period hereunder
or (iv) to change or supplement the provisions hereunder in any manner that the Company may deem necessary or desirable and that
shall not adversely affect the interests of the holders of Rights Certificates (other than an Acquiring Person or an Affiliate
or Associate of an Acquiring Person). Upon the delivery of a certificate from an appropriate officer of the Company that states
that the proposed supplement or amendment is in compliance with the terms of this Section 27, the Rights Agent shall execute such
supplement or amendment; provided, that the Rights Agent may, but shall not be obligated to, enter into any supplement or amendment
that affects the Rights Agent’s own rights, duties, obligations or immunities under this Agreement. Notwithstanding anything
herein to the contrary, this Agreement may not be amended (other than pursuant to clauses (i) or (ii) of the third sentence of
this Section 27) at a time when the Rights are not redeemable.
Section 28.
Successors
.
All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent shall bind and inure
to the benefit of their respective successors and assigns hereunder.
Section 29.
Determinations
and Actions by the Board of Directors, etc.
For all purposes of this Agreement, any calculation of the number of shares of
Common Stock or any other class of capital stock outstanding at any particular time, including for purposes of determining the
particular percentage of such outstanding shares of Common Stock of which any Person is the Beneficial Owner, shall be made in
accordance with the last sentence of Rule
13d-3(d)(1)(i) of the General Rules and Regulations under the Exchange Act. The Board shall have the exclusive power and authority
to administer this Agreement and to exercise all rights and powers specifically granted to the Board or to the Company, or as
may be necessary or advisable in the administration of this Agreement, including, without limitation, the right and power to (i)
interpret the provisions of this Agreement, and (ii) make all determinations deemed necessary or advisable for the administration
of this Agreement (including a determination to redeem or not redeem the Rights or to amend the Agreement, and any determination
as to whether actions of any Person shall be such as to cause such Person to beneficially own shares held by another Person).
All such actions, calculations, interpretations, and determinations (including, for purposes of clause (y) below, all omissions
with respect to the foregoing) which are done or made by the Board in good faith, shall (x) be final, conclusive, and binding
on the Company, the Rights Agent, the holders of the Rights, and all other parties, and (y) not subject the Board or any of the
directors to any liability to the holders of the Rights.
Section 30.
Benefits
of this Agreement.
Nothing in this Agreement shall be construed to give to any Person other than the Company, the Rights Agent,
and the registered holders of the Rights Certificates (and, prior to the Distribution Date, registered holders of the Common Stock)
any legal or equitable right, remedy, or claim under this Agreement; but this Agreement shall be for the sole and exclusive benefit
of the Company, the Rights Agent, and the registered holders of the Rights Certificates (and, prior to the Distribution Date,
registered holders of the Common Stock).
Section 31.
Severability.
If any term, provision, covenant, or restriction of this Agreement is held by a court of competent jurisdiction or other authority
to be invalid, void, or unenforceable, the remainder of the terms, provisions, covenants, and restrictions of this Agreement shall
remain in full force and effect and shall in no way be affected, impaired, or invalidated; provided, however, that notwithstanding
anything in this Agreement to the contrary, if any such term, provision, covenant, or restriction is held by such court or authority
to be invalid, void, or unenforceable and the Board determines in its good faith judgment that severing the invalid language from
this Agreement would adversely affect the purpose or effect of this Agreement, the right of redemption set forth in Section 23
hereof shall be reinstated and shall not expire until the close of business on the tenth Business Day following the date of such
determination by the Board of Directors.
Section 32.
Governing
Law.
This Agreement, each Right, and each Rights Certificate issued hereunder shall be deemed to be a contract made under
the laws of the State of New York and for all purposes shall be governed by and construed in accordance with the laws of such
State applicable to contracts made and to be performed entirely within such State.
Section 33.
Counterparts.
This Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed
to be an original, and all such counterparts shall together constitute but one and the same instrument.
Section 34.
Descriptive
Headings.
Descriptive headings of the several Sections of this Agreement are inserted for convenience only and shall not control
or affect the meaning or construction of any of the provisions hereof.
Section 35.
Force
Majeure.
Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays or
failures in performance resulting from acts beyond its reasonable control including, without limitation, acts of God, terrorist
acts, shortage of supply, breakdowns or malfunctions, interruptions or malfunction of computer facilities, or loss of data due
to power failures or mechanical difficulties with information.
* * * SIGNATURE PAGE FOLLOWS
* * *
IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be duly executed, all as of the day and year first above written.
|
ANAVEX LIFE SCIENCES CORP.
|
|
|
|
|
By
|
|
|
Name:
|
|
|
Title:
|
|
|
|
|
|
______________________________
|
|
|
|
|
By
|
|
|
Name:
|
|
|
Title:
|
|
Exhibit A
Form of Rights Certificate
Certificate No. R-
|
________ Rights
|
NOT EXERCISABLE AFTER APRIL ___, 2020
(UNLESS EXTENDED PRIOR THERETO BY THE BOARD OF DIRECTORS), OR EARLIER IF REDEEMED BY THE COMPANY. THE RIGHTS ARE SUBJECT TO REDEMPTION,
AT THE OPTION OF THE COMPANY, AT $0.001 PER RIGHT ON THE TERMS SET FORTH IN THE RIGHTS AGREEMENT. UNDER CERTAIN CIRCUMSTANCES,
RIGHTS BENEFICIALLY OWNED BY AN ACQUIRING PERSON (AS SUCH TERM IS DEFINED IN THE RIGHTS AGREEMENT) AND ANY SUBSEQUENT HOLDER OF
SUCH RIGHTS MAY BECOME NULL AND VOID. [THE RIGHTS REPRESENTED BY THIS RIGHTS CERTIFICATE ARE OR WERE BENEFICIALLY OWNED BY A PERSON
WHO WAS OR BECAME AN ACQUIRING PERSON OR AN AFFILIATE OR ASSOCIATE OF AN ACQUIRING PERSON (AS SUCH TERMS ARE DEFINED IN THE RIGHTS
AGREEMENT). ACCORDINGLY, THIS RIGHTS CERTIFICATE AND THE RIGHTS REPRESENTED HEREBY MAY BECOME NULL AND VOID IN THE CIRCUMSTANCES
SPECIFIED IN SECTION 7(e) OF SUCH AGREEMENT.
Rights Certificate
Anavex Life Sciences Corp.
This certifies that __________, or registered assigns, is the registered owner of the number of Rights
set forth above, each of which entitles the owner thereof, subject to the terms, provisions and conditions of the Rights Agreement,
dated as of ________ ___, 2017 (the “
Rights Agreement
”), between Anavex Life Sciences Corp., a Nevada corporation
(the “
Company
”), and ________________________ (the “
Rights Agent
”), to purchase from the
Company at any time prior to 5:00 P.M. New York City time on ________ 31, 2020 at the office or offices of the Rights Agent designated
for such purpose, or its successors as Rights Agent, one fully paid and non-assessable share of Common Stock (the “
Common
Stock
”) of the Company, at a purchase price of $26.80 per one share (the “
Purchase Price
”), upon presentation
and surrender of this Rights Certificate with the Form of Election to Purchase and related Certificate duly executed. The number
of Rights evidenced by this Rights Certificate (and the number of shares which may be purchased upon exercise thereof) set forth
above, and the Purchase Price per share set forth above, are the number and Purchase Price as of ________ ___, 20__ based on the
Common Stock as constituted at such date. The Company reserves the right to require prior to the occurrence of a Triggering Event
(as such term is defined in the Rights Agreement) that a number of Rights be exercised so that only whole shares of Common Stock
will be issued.
Upon the occurrence of
a Section 11(a)(ii) Event (as such term is defined in the Rights Agreement), if the Rights evidenced by this Rights Certificate
are beneficially owned by (i) an Acquiring Person or an Affiliate or Associate of any such Acquiring Person (as such terms are
defined in the Rights Agreement), (ii) a transferee of any such Acquiring Person, Associate, or Affiliate, or (iii) under certain
circumstances specified in the Rights Agreement, a transferee of a person who, after such transfer, became an Acquiring Person,
or an Affiliate or Associate of an Acquiring Person, such Rights shall become null and void and no holder hereof shall have any
right with respect to such Rights from and after the occurrence of such Section 11(a)(ii) Event.
As provided in the Rights
Agreement, the Purchase Price and the number and kind of shares of Common Stock or other securities which may be purchased upon
the exercise of the Rights evidenced by this Rights Certificate are subject to modification and adjustment upon the happening
of certain events, including Triggering Events.
This Rights Certificate
is subject to all of the terms, provisions, and conditions of the Rights Agreement, which terms, provisions, and conditions are
hereby incorporated herein by reference and made a part hereof and to which Rights Agreement reference is hereby made for a full
description of the rights, limitations of rights, obligations, duties, and immunities hereunder of the Rights Agent, the Company,
and the holders of the Rights Certificates, which limitations of rights include the temporary suspension of the exercisability
of such Rights under the specific circumstances set forth in the Rights Agreement. Copies of the Rights Agreement are on file
at the above-mentioned office of the Rights Agent and are also available upon written request to the Rights Agent.
This Rights Certificate,
with or without other Rights Certificates, upon surrender at the principal office or offices of the Rights Agent designated for
such purpose, may be exchanged for another Rights Certificate or Rights Certificates of like tenor and date evidencing Rights
entitling the holder to purchase a like aggregate number of shares of Common Stock as the Rights evidenced by the Rights Certificate
or Rights Certificates surrendered shall have entitled such holder to purchase. If this Rights Certificate shall be exercised
in part, the holder shall be entitled to receive upon surrender hereof another Rights Certificate or Rights Certificates for the
number of whole Rights not exercised.
Subject to the
provisions of the Rights Agreement, the Rights evidenced by this Certificate may be redeemed by the Company at its option at
a redemption price of $0.001 per Right at any time prior to (i) the close of business on the tenth Business Day following the
“Stock Acquisition Date”, which is the first date of a public announcement that a person has become an Acquiring
Person, and (ii) the Final Expiration Date. In addition, the Rights may be exchanged, in whole or in part, at the
Company’s option, for shares of the Common Stock of the Company. Immediately upon the action of the Board authorizing
any such exchange, and without any further action or any notice, the Rights (other than Rights which are not subject to such
exchange) will terminate and the Rights will only enable holders to receive the shares issuable upon such exchange.
No fractional shares of
Common Stock will be issued upon the exercise of any Right or Rights evidenced hereby, but in lieu thereof a cash payment will
be made, as provided in the Rights Agreement.
No holder of this Rights
Certificate shall be entitled to vote or receive dividends or be deemed for any purpose the holder of shares of Common Stock or
of any other securities of the Company, which may at any time be issuable on the exercise hereof, nor shall anything contained
in the Rights Agreement or herein be construed to confer upon the holder hereof, as such, any of the rights of a stockholder of
the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof,
or to give or withhold consent to any corporate action, or to receive notice of meetings or other actions affecting stockholders
(except as provided in the Rights Agreement), or to receive dividends or subscription rights, or otherwise, until the Right or
Rights evidenced by this Rights Certificate shall have been exercised as provided in the Rights Agreement.
This Rights Certificate
shall not be valid or obligatory for any purpose until it shall have been countersigned by the Rights Agent.
WITNESS the facsimile
signature of the proper officers of the Company and its corporate seal.
Dated as of ______________ ___, ___
|
ATTEST:
|
|
|
ANAVEX LIFE SCIENCES CORP.
|
|
|
|
|
|
|
|
|
By:
|
|
|
Secretary
|
|
|
Name
|
|
|
|
|
Title:
|
|
Countersigned:
|
|
|
|
|
_____________________________________
|
Form of Reverse Side of Rights Certificate
FORM OF ASSIGNMENT
(To be executed by the registered holder if
such
holder desires to transfer the Rights Certificate.)
FOR VALUE RECEIVED
hereby sells, assigns, and transfers unto
(Please print name and address of transferee)
this Rights Certificate, together with all
right, title, and interest therein, and does hereby irrevocably constitute and appoint _________________ Attorney, to transfer
the within Rights Certificate on the books of the within-named Company, with full power of substitution.
Dated:
|
___________________, ____
|
|
|
|
|
|
|
Signature
|
|
Signature Guaranteed:
Certificate
The undersigned hereby
certifies by checking the appropriate boxes that:
(1) this Rights Certificate
is / is not being sold, assigned, and transferred by or on behalf of a Person who is or was an Acquiring Person
or an Affiliate or Associate of any such Acquiring Person (as such terms are defined in the Rights Agreement);
(2) after due inquiry
and to the best knowledge of the undersigned, it did / did not acquire the Rights evidenced by this Rights Certificate
from any Person who is, was, or subsequently became an Acquiring Person or an Affiliate or Associate of an Acquiring Person.
Dated:
|
___________________, ____
|
|
|
|
|
|
|
Signature
|
|
NOTICE
The signature to the foregoing
Assignment and Certificate must correspond to the name as written upon the face of this Rights Certificate in every particular,
without alteration or enlargement or any change whatsoever.
FORM OF ELECTION TO PURCHASE
(To be executed if holder desires
to
exercise Rights represented by the
Rights Certificate.)
To: Anavex
Life Sciences Corp.
The undersigned hereby
irrevocably elects to exercise __________ Rights represented by this Rights Certificate to purchase the shares of Common Stock
issuable upon the exercise of the Rights (or such other securities of the Company or of any other person which may be issuable
upon the exercise of the Rights) and requests that certificates for such shares be issued in the name of and delivered to:
Please insert social security
|
or other identifying number
|
|
(Please print name and address)
|
|
|
If such number of Rights
shall not be all the Rights evidenced by this Rights Certificate, a new Rights Certificate for the balance of such Rights shall
be registered in the name of and delivered to:
Please insert social security
|
or other identifying number
|
|
(Please print name and address)
|
|
|
Dated:
|
___________________, ____
|
|
|
|
|
|
|
Signature
|
|
Signature Guaranteed:
Certificate
The undersigned hereby certifies by checking
the appropriate boxes that:
(1) the Rights evidenced
by this Rights Certificate are / are not being exercised by or on behalf of a Person who is or was an Acquiring
Person or an Affiliate or Associate of any such Acquiring Person (as such terms are defined pursuant to the Rights Agreement);
(2) after due inquiry
and to the best knowledge of the undersigned, it did / did not acquire the Rights evidenced by this Rights Certificate
from any Person who is, was, or became an Acquiring Person or an Affiliate or Associate of an Acquiring Person.
Dated:
|
___________________, ____
|
|
|
|
|
|
|
Signature
|
|
Signature Guaranteed:
NOTICE
The signature to the foregoing
Election to Purchase and Certificate must correspond to the name as written upon the face of this Rights Certificate in every
particular, without alteration or enlargement or any change whatsoever.
Exhibit B
SUMMARY
OF RIGHTS TO PURCHASE
COMMON
STOCK
On _______________,
2017, the Board of Directors (the “
Board
”) of Anavex Life Sciences Corp. (the “Company”) declared
a dividend distribution of one Right for each outstanding share of common stock (“Common Stock”) to stockholders of
record at the close of business on ________ ___, 2017 (the “Record Date”). Each Right entitles the registered holder
to purchase from the Company one share of Common Stock, par value $0.001 per share (the “Common Stock”), at a Purchase
Price of $26.80, subject to adjustment. The description and terms of the Rights are set forth in a Rights Agreement (the “Rights
Agreement”) between the Company and _______________________, as Rights Agent.
Initially, the Rights
will be attached to all Common Stock certificates representing shares then outstanding, and no separate Rights Certificates will
be distributed. Subject to certain exceptions specified in the Rights Agreement, the Rights will separate from the Common Stock
and a “Distribution Date” will occur upon the earlier of (i) ten Business Days following a public announcement that
a person or group of affiliated or associated persons (an “Acquiring Person”) has acquired beneficial ownership of
ten percent or more, or fifteen percent or more if such person or group owned ten percent or more on the adoption date of the
Rights Agreement, of the outstanding shares of Common Stock (the “Stock Acquisition Date”), other than as a result
of repurchases of stock by the Company or (ii) ten Business Days (or such later date as the Board shall determine) following the
commencement of a tender offer or exchange offer that would result in a person or group becoming an Acquiring Person. Until the
Distribution Date, (i) the Rights will be evidenced by the Common Stock certificates and will be transferred with and only with
such Common Stock certificates, (ii) new Common Stock certificates issued after the Record Date will contain a notation incorporating
the Rights Agreement by reference, and (iii) the surrender for transfer of any certificates for Common Stock outstanding will
also constitute the transfer of the Rights associated with the Common Stock represented by such certificate. Pursuant to the Rights
Agreement, the Company reserves the right to require prior to the occurrence of a Triggering Event (as defined below) that, upon
any exercise of Rights, a number of Rights be exercised so that only whole shares of Common Stock will be issued.
The Rights are not
exercisable until the Distribution Date and will expire at 5:00 P.M. New York City time on ________ 31, 2020, unless earlier
redeemed, exchanged, or extended by the Company.
As soon as practicable
after the Distribution Date, Rights Certificates will be mailed to holders of record of the Common Stock as of the close of business
on the Distribution Date and, thereafter, the separate Rights Certificates alone will represent the Rights. Except as otherwise
determined by the Board, only shares of Common Stock issued prior to the Distribution Date will be issued with Rights.
In the event that a person
becomes an Acquiring Person, each holder of a Right will thereafter have the right to receive, upon exercise, Common Stock (or,
in certain circumstances, cash, property, or other securities of the Company) having a value equal to two times the exercise price
of the Right. Notwithstanding any of the foregoing, following the occurrence of the event set forth in this paragraph, all Rights
that are, or (under certain circumstances specified in the Rights Agreement) were, beneficially owned by any Acquiring Person
will be null and void. However, Rights are not exercisable following the occurrence of the event set forth above until such time
as the Rights are no longer redeemable by the Company as set forth below.
For example, at an
exercise price of $20.00 per Right, each Right not owned by an Acquiring Person (or by certain related parties) following an
event set forth in the preceding paragraph would entitle its holder to purchase $40.00 worth of Common Stock (or other
consideration, as noted above) for $20.00. Assuming that the Common Stock had a per share value of $2.00 at such time, the
holder of each valid Right would be entitled to purchase twenty shares of Common Stock for $20.00.
In the event that, at
any time following the Stock Acquisition Date, (i) the Company engages in a merger or other business combination transaction in
which the Company is not the surviving corporation, (ii) the Company engages in a merger or other business combination transaction
in which the Company is the surviving corporation and the Common Stock of the Company is changed or exchanged, or (iii) fifty
percent or more of the Company’s assets, cash flow, or earning power is sold or transferred, each holder of a Right (except
Rights which have previously been voided as set forth above) shall thereafter have the right to receive, upon exercise, common
stock of the acquiring company having a value equal to two times the exercise price of the Right. The events set forth in this
paragraph and in the second preceding paragraph are referred to as the “Triggering Events.”
At any time after a person
becomes an Acquiring Person and prior to the acquisition by such person or group of fifty percent or more of the outstanding Common
Stock, the Board may exchange the Rights (other than Rights owned by such person or group which have become void), in whole or
in part, at an exchange ratio of one share of Common Stock per Right (subject to adjustment).
Subject to the
terms of the Rights Agreement, at any time prior to such time as any Person becomes an Acquiring Person, the Company may
redeem the Rights in whole, but not in part, at a price of $0.001 per Right (payable in cash, Common Stock, or other
consideration deemed appropriate by the Board). Immediately upon the action of the Board ordering redemption of the Rights,
the Rights will terminate and the only right of the holders of Rights will be to receive the $0.001 redemption
price.
Until a Right is exercised,
the holder thereof, as such, will have no rights as a stockholder of the Company, including, without limitation, the right to
vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders
may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for Common Stock
(or other consideration) of the Company or for common stock of the acquiring company as set forth above.
Any of the provisions
of the Rights Agreement may be amended by the Board prior to the Distribution Date. After the Distribution Date, the provisions
of the Rights Agreement may be amended by the Board in order to cure any ambiguity, to make changes that do not adversely affect
the interests of holders of Rights, or to shorten or lengthen any time period under the Rights Agreement; provided, however, that
no amendment to lengthen a time period relating to when the Rights may be redeemed may be made at such time as the Rights are
not redeemable.
A copy of the Rights Agreement
is being filed with the Securities and Exchange Commission as an Exhibit to a Registration Statement on Form 8-A. A copy of the
Rights Agreement is available free of charge from the Company. This summary description of the Rights does not purport to be complete
and is qualified in its entirety by reference to the Rights Agreement, which is incorporated herein by reference.
ANAVEX LIFE SCIENCES CORP.